{"content": "\n\n\n\n\n\n\n\n\nMIAMI, March  30, 2016  (GLOBE NEWSWIRE) -- Spanish Broadcasting System, Inc. (SBSA) (the \u201cCompany\u201d) announced today that it will release its fourth quarter and full year 2015 financial results after the close of market on Wednesday, March 30, 2016. The Company will host a conference call to discuss its fourth quarter and full year 2015 financial results on Friday, April 1, 2016 at 11:00 a.m. Eastern Time. To access the teleconference, please dial 412-858-4600 ten minutes prior to the start time. If you cannot listen to the teleconference at its scheduled time, there will be a replay available through Friday, April 15, 2016 which can be accessed by dialing 877-344-7529 (U.S) or 412-317-0088 (Int\u2019l), passcode: 10082684.\u00a0 There will also be a live webcast of the teleconference, located on the investor portion of Spanish Broadcasting\u2019s corporate web site, at www.spanishbroadcasting.com/webcasts.shtml. A seven day archived replay of the webcast will also be available at that link.\u00a0 About Spanish Broadcasting System, Inc. \u00a0\u00a0 Spanish Broadcasting System, Inc. owns and operates 17 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Spanish Tropical, Regional Mexican, Spanish Adult Contemporary, Top 40 and Latin Rhythmic format genres. SBS also operates AIRE Radio Network, a national radio platform which creates, distributes and markets leading Spanish-language radio programming to over 100 affiliated stations reaching 90% of the U.S. Hispanic audience. SBS also owns MegaTV, a television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico. SBS also produces live concerts and events and owns multiple bilingual websites, including www.LaMusica.com, an online destination and mobile app providing content related to Latin music, entertainment, news and culture. For more information, visit us online at www.spanishbroadcasting.com. .gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} <p>.gnwtablebottommargin {margin-bottom: 10.0px !important;} <p>.gnwcellpaddingleft0 {padding-left: 0.0px !important;} <p>.gnwverticalaligntop {vertical-align: top !important;} <p>.gnwtextaligncenter {text-align: center !important;} <p>.gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} <p>.gnwverticalalignbottom {vertical-align: bottom !important;} <p>.gnwwhitespacenowrap {white-space: nowrap !important;} <p>.gnwtextalignright {text-align: right !important;} <p>.gnwcellpaddingright0 {padding-right: 0.0px !important;} <p>.gnwunderlinestyle {text-decoration: underline !important;} <p>.gnwtextalignleft {text-align: left !important;} <p>.gnw_ol {position: relative !important; left: 10px !important;} <p>.gnw_ul {position: relative !important; left: 10px !important;} <p>.gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} <p>.gnw_border_top_solid {border-top: solid black 1px !important;} <p>.gnw_border_right_solid {border-right: solid black 1px !important;} <p>.gnw_border_bottom_solid {border-bottom: solid black 1px !important;} <p>.gnw_border_left_solid {border-left: solid black 1px !important;} <p>.gnw_border_top_double {border-top: double black 3px !important;} <p>.gnw_border_right_double {border-right: double black 3px !important;} <p>.gnw_border_bottom_double {border-bottom: double black 3px !important;} <p>.gnw_border_left_double {border-left: double black 3px !important;} <p>.gnw_table_border_collapse {border-collapse: collapse !important;} <p>.gnw_align_left {text-align: left !important;} <p>.gnw_align_center {text-align: center !important;} <p>.gnw_align_right {text-align: right !important;} <p>.gnw_align_justify {text-align: justify !important;} <p>.gnw_vertical_align_top {vertical-align: top !important;} <p>.gnw_vertical_align_middle {vertical-align: middle !important;} <p>.gnw_vertical_align_bottom {vertical-align: bottom !important;} <p>.gnw_padding_left_none {padding-left: 0 !important;} <p>.gnw_padding_right_none {padding-right: 0 !important;} <p>.gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} <p>.gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} <p>.gnw_heading {font: 16px Arial; text-align: center !important;} <p>.gnw_subhead {font: 12px Arial; text-align: center !important;} <p>.gnw_colhead {font: 12px Arial; text-align: center !important;} <p>.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} <p>.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} <p>.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} <p>.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} <p>.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} <p>.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} <p>.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} <p>.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} <p>.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} <p>.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} <p>.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} <p>.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} <p>.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} <p>.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} <p>.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} <p>.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} <p>.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} <p>.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} <p>.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} <p>.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} <p>.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} <p>.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} <p>.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} <p>.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} <p>.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} <p>.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>.gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} <p>.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} <p>.gnw_media_bgcolor {background-color: transparent !important;} <p>.gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} <p>.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} <p>td.gnw_heading {font: 16px Arial; text-align: center !important;} <p>td.gnw_subhead {font: 12px Arial; text-align: center !important;} <p>td.gnw_colhead {font: 12px Arial; text-align: center !important;} <p>td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} <p>td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} <p>td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} <p>td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} <p>td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} <p>td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} <p>td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} <p>td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} <p>td.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} <p>td.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} <p>td.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} <p>td.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} <p>td.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} <p>td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} <p>td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} <p>td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} <p>td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} <p>td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} <p>td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} <p>td.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} <p>td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} <p>td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} <p>td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} <p>td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} <p>td.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} <p>td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>td.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} <p>td.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} <p>;} <p>          Company EarningsSpanish Broadcasting System\n\n\n                    Contact:\n                \n\nContacts:Analysts and Investors\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Joseph A. Garcia\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0  Chief Financial Officer\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (305) 441-6901\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Analysts, Investors or MediaBrad EdwardsBrainerd Communicators, Inc.(212) 986-6667          \n\n\n\n", "title": "Spanish Broadcasting System Schedules Fourth Quarter and Full Year 2015 Conference Call", "symbols": ["SBSA", "SBSA"], "link": "http://finance.yahoo.com/news/spanish-broadcasting-system-schedules-fourth-144033278.html", "date": "6 hours ago", "_id": {"$oid": "56fc80f7fb1fdb5e35baa8f0"}, "nes": {"DATE": ["2015", "Friday, April 1, 2016", "Friday, April 15, 2016", "March  30, 2016", "March 30, 2016", "Wednesday", "fourth quarter"], "ORGANIZATION": ["AIRE Radio Network", "Eastern Time", "Inc.", "SBS", "Spanish Broadcasting", "Spanish Broadcasting System, Inc", "Spanish Broadcasting System, Inc."], "PERCENT": ["90%"], "LOCATION": ["Chicago", "Los Angeles", "MIAMI", "Miami", "New York", "Puerto Rico", "San Francisco", "U.S."]}}
{"content": "\n\n\n\n\n\n\n\n\nPALM DESERT, Calif., March 30, 2016 (GLOBE NEWSWIRE) -- Associa Desert Resort Management congratulates Terry Kramer on his recent appointment to a state committee which reviews, updates and revises testing for security guards. This will be a joint committee serving the California Association of Licensed Security Agencies, Guards and Associates (CALSAGA) and the Bureau of Security and Investigative Services (BSIS).\tKramer is the director of operations for Palm Valley HOA, a 1,274 unit Palm Desert community, managed by Associa Desert Resort Management. He also serves in a leadership role at Associa Desert Resort Management monitoring internal work safety for the maintenance division and security license compliance for the access control division. Before joining Associa, Kramer spent 28 years in law enforcement as a DPS police officer and firefighter.\t\"I was asked to be a part of this committee by the president of CALSAGA based on my law enforcement career and extensive work in the security field,\" said Kramer.  \"The Coachella Valley is home to a large number of gated communities and many of these communities have security guard service. I have been very active throughout the region working with several of the communities providing site inspections and reviews of their current security measures and electronic surveillance programs.\"\tThe committee will be tasked with reviewing the current testing for new security guards. After reviewing the testing modules, they will then update and revise the modules to ensure they are accurate with the current laws and standards for the industry.\tBuilding and managing successful communities for more than 35 years, Associa is the worldwide leader in community management with over 10,000 employees operating more than 180 branch offices in the United States, Mexico, Canada, the United Arab Emirates and South Africa. Based in Dallas, Texas, our industry expertise, financial strength, and innovation meet the unique needs of clients across the world with customized services and solutions designed to help communities achieve their vision. To learn more about Associa and its charitable organization, Associa Cares, go to www.associaonline.com or www.associacares.com. Stay Connected:\tFacebook: https://www.facebook.com/associa \tTwitter: https://twitter.com/associa \tLinkedIn: http://www.linkedin.com/company/associa \tPinterest: http://pinterest.com/associa/ \tYouTube: http://www.youtube.com/associamarketing \tGoogle+: https://plus.google.com/+Associaonline/.gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} .gnwtablebottommargin {margin-bottom: 10.0px !important;} .gnwcellpaddingleft0 {padding-left: 0.0px !important;} .gnwverticalaligntop {vertical-align: top !important;} .gnwtextaligncenter {text-align: center !important;} .gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} .gnwverticalalignbottom {vertical-align: bottom !important;} .gnwwhitespacenowrap {white-space: nowrap !important;} .gnwtextalignright {text-align: right !important;} .gnwcellpaddingright0 {padding-right: 0.0px !important;} .gnwunderlinestyle {text-decoration: underline !important;} .gnwtextalignleft {text-align: left !important;} .gnw_heading {font: 16px Arial; text-align: center !important;} .gnw_subhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} td.gnw_num          {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} td.gnw_data         {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_news_media_box  {float: left !important; margin: 6px !important; border: solid 1px #a9a9a9 !important; width: 250px !important;} .gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} .gnw_media_bgcolor {background-color: transparent !important;} .gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} .gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} .gnw_ol {position: relative !important; left: 10px !important;} .gnw_ul {position: relative !important; left: 10px !important;} .gnw_border_top_solid {border-top: solid black 1px !important;} .gnw_border_right_solid {border-right: solid black 1px !important;} .gnw_border_bottom_solid {border-bottom: solid black 1px !important;} .gnw_border_left_solid {border-left: solid black 1px !important;} .gnw_border_top_double {border-top: double black 3px !important;} .gnw_border_right_double {border-right: double black 3px !important;} .gnw_border_bottom_double {border-bottom: double black 3px !important;} .gnw_border_left_double {border-left: double black 3px !important;} .gnw_table_border_collapse {border-collapse: collapse !important;} .gnw_table_border_collapse td {padding-left: 3px !important; padding-right: 3px !important;} .gnw_align_left {text-align: left !important;} .gnw_align_center {text-align: center !important;} .gnw_align_right {text-align: right !important;} .gnw_align_justify {text-align: justify !important;} .gnw_vertical_align_top {vertical-align: top !important;} .gnw_vertical_align_middle {vertical-align: middle !important;} .gnw_vertical_align_bottom {vertical-align: bottom !important;} ;} Professional Servicessecurity guards\n\n\n                    Contact:\n                \n\nBilly Rudolph214-272-4107brudolph@associaonline.com\n\n\n\n", "title": "Associa Desert Resort Management's Terry Kramer Appointed to State Security Committee", "symbols": [], "link": "http://finance.yahoo.com/news/associa-desert-resort-managements-terry-142856445.html", "date": "6 hours ago", "_id": {"$oid": "56fc80f7fb1fdb5e35baa8f1"}, "nes": {"DATE": ["March 30, 2016"], "ORGANIZATION": ["Associa", "Associa Cares", "Associa Desert Resort Management", "Bureau of Security and Investigative Services", "California Association of Licensed Security Agencies", "DPS", "Google", "Palm Valley HOA", "United Arab Emirates"], "LOCATION": ["Calif.", "Canada", "Coachella Valley", "DESERT", "Dallas", "Geneva", "Helvetica", "Mexico", "Palm Desert", "South Africa", "Texas", "United States", "Verdana"], "PERSON": ["Billy Rudolph214-272-4107brudolph@associaonline.com", "Kramer", "Terry Kramer"]}}
{"content": "\n\n\n\n\n\n\n\n\nSHELTON, Conn., March 30, 2016 (GLOBE NEWSWIRE) -- Highlights:\t-- New MY01 LIME Tag provides integrated Cellular, Bluetooth Low Energy (BLE), classic Bluetooth, and Near Field Communication (NFC) connectivity on single platform with security and sensors\t-- MY01 utilizes Public-Key Infrastructure (PKI) for identification/authentication and symmetric security for on-tag data protection \t-- Integrates with Veridify(R) Internet of Things (IoT) cloud-based platform for real-time visibility and monitoring\t-- LIME Tag Credential and Smartcard (NX01) updated with symmetric encryption features to its Public-Key authentication and access controls\t-- NX01 now supports multiple data files with customizable read/write access controls\t-- Smartphone Apps, software development kits, and supporting applications available for rapid deployment of all LIME Tags\t-- Custom designs and form-factors to address your secure sensor needs\tSecureRF, a leading provider of security solutions for the Internet of Things (IoT), announced today the availability of a new sensor LIME Tag(TM) (MY01) with Cellular, BLE, classic Bluetooth, and NFC connectivity. The company also announced an updated credential and smartcard LIME Tag (NX01) supporting Public Key Infrastructure, symmetric encryption features, and multiple file support.\tThe MY01 tag provides a robust sensor and connectivity platform integrated with SecureRF's Public-Key Infrastructure and file protection solutions. This LIME Tag has cellular, BLE, classic Bluetooth, and NFC radios, and an optional temperature sensor, 3-axis accelerometer, an ambient light sensor, and over 7 Mbytes of storage. In addition to supporting SMS, the MY01 support GPS functions for location-oriented services. The tag also has an optional 240 X 240 pixel (1.5 X 1.5 inch) color touchscreen display. A security Software Development Kit, Smartphone App, and supporting infrastructure are available for easy customization and fast deployment. Data and messaging to and from the tag can be managed through Veridify, SecureRF's secure cloud-based IoT service platform.\tSecureRF is also introducing updated features to the NX01 LIME Tag credentialing solution, including onboard file protection, identification, and authentication via Public-Key Infrastructure; and a symmetric encryption engine to securely move data on and off the smartcard. Smartphone and reader Apps can support up to 40K bytes of user data in multiple files with user-defined access.\tAll LIME Tags utilize Public-Key Infrastructure (PKI) technology enabling real-time identification and authentication with or without a supporting database or internet connectivity while performing an authentication. LIME Tags are suitable for securing supply chains, monitoring high-value assets, cold chain management, and wherever pedigree and chain-of-custody is important.\tSecureRF CEO, Louis Parks said, \"Our new and updated LIME Tags address the challenge of delivering strong, easy-to-use authentication and data protection for devices and products now becoming part of the IoT.\" Parks continued, \"Managing every transaction with network-connected security methods is becoming harder and harder. Together with our smartphone apps, software development kits and tools, LIME Tags enable rapid customization and deployment with network-free authentication.\"\tLIME Tags are designed to fit a wide range of commercial, consumer, and defense applications, where people, devices, and products need to be securely monitored and authenticated. Sensors and tags are available in a variety of physical forms including inlays, smartcards, or chips, for easy integration into existing products, labels or tags. LIME Tags can also collect critical sensor data like temperature, humidity, and shock.\tUsed in conjunction with SecureRF's Veridify smartphone app/reader and a secure cloud-based dashboard, the LIME Tags deliver real-time visibility and provide a range of in-field control features including the ability to revoke or un-revoke a tag's 'certificate of authenticity', in essence turning its authentication \"on\" or \"off\" after deployment.\tFor information, demonstration or an evaluation kit, visit: www.securerf.com or call (203) 227-3151.About SecureRF\tSecureRF Corporation -- Securing the Internet of Things(R) -- provides security solutions for passive, battery-assisted, and active tags, wireless sensors, and embedded platforms including FPGAs, Microcontrollers, and ASICs based on a breakthrough in Public-Key Cryptography that is computationally efficient, yet highly secure. Applications include non-traditional payment systems, high-value supply chain management, cold chain management, and anti-counterfeiting applications in the pharmaceutical, consumer, defense, and homeland security sectors. Under the Veridify(R) banner, the company delivers a comprehensive cloud-based IoT solution for quickly and easily giving devices and products a secure place in the Internet of Things. For more information on securing the Internet of Things, please contact us at info@SecureRF.com. More information about SecureRF can be found at www.SecureRF.com.\tSecureRF's insights on security can be found on its blog at www.SecureRF.com/blog. Follow us on Twitter, Linkedin and Facebook.\tSecureRF, LIME Tag, Veridify, and Securing the Internet of Things are trademarks, service marks or registered trademarks of SecureRF Corporation\tA photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=39636.gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} .gnwtablebottommargin {margin-bottom: 10.0px !important;} .gnwcellpaddingleft0 {padding-left: 0.0px !important;} .gnwverticalaligntop {vertical-align: top !important;} .gnwtextaligncenter {text-align: center !important;} .gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} .gnwverticalalignbottom {vertical-align: bottom !important;} .gnwwhitespacenowrap {white-space: nowrap !important;} .gnwtextalignright {text-align: right !important;} .gnwcellpaddingright0 {padding-right: 0.0px !important;} .gnwunderlinestyle {text-decoration: underline !important;} .gnwtextalignleft {text-align: left !important;} .gnw_heading {font: 16px Arial; text-align: center !important;} .gnw_subhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} td.gnw_num          {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} td.gnw_data         {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_news_media_box  {float: left !important; margin: 6px !important; border: solid 1px #a9a9a9 !important; width: 250px !important;} .gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} .gnw_media_bgcolor {background-color: transparent !important;} .gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} .gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} .gnw_ol {position: relative !important; left: 10px !important;} .gnw_ul {position: relative !important; left: 10px !important;} .gnw_border_top_solid {border-top: solid black 1px !important;} .gnw_border_right_solid {border-right: solid black 1px !important;} .gnw_border_bottom_solid {border-bottom: solid black 1px !important;} .gnw_border_left_solid {border-left: solid black 1px !important;} .gnw_border_top_double {border-top: double black 3px !important;} .gnw_border_right_double {border-right: double black 3px !important;} .gnw_border_bottom_double {border-bottom: double black 3px !important;} .gnw_border_left_double {border-left: double black 3px !important;} .gnw_table_border_collapse {border-collapse: collapse !important;} .gnw_table_border_collapse td {padding-left: 3px !important; padding-right: 3px !important;} .gnw_align_left {text-align: left !important;} .gnw_align_center {text-align: center !important;} .gnw_align_right {text-align: right !important;} .gnw_align_justify {text-align: justify !important;} .gnw_vertical_align_top {vertical-align: top !important;} .gnw_vertical_align_middle {vertical-align: middle !important;} .gnw_vertical_align_bottom {vertical-align: bottom !important;} ;} Professional ServicesPublic-Key InfrastructureInternet of Things\n\n\n                    Contact:\n                \n\nJackie Gratz Marketing@SecureRF.com203-227-3151\n\n\n\n", "title": "SecureRF Announces Multi-Mode Sensor LIME Tag(TM) for the IoT, and an Update to its Credentialing So \u2026", "symbols": [], "link": "http://finance.yahoo.com/news/securerf-announces-multi-mode-sensor-140526650.html", "date": "6 hours ago", "_id": {"$oid": "56fc80f7fb1fdb5e35baa8f2"}, "nes": {"DATE": ["March 30, 2016"], "ORGANIZATION": ["Bluetooth Low Energy", "IoT", "Microcontrollers", "NFC", "Near Field Communication"], "LOCATION": ["Conn.", "Geneva", "Helvetica", "SHELTON", "Verdana"], "PERSON": ["Jackie Gratz Marketing@SecureRF.com203-227-3151", "Linkedin", "Louis Parks", "Smartphone App", "Veridify"]}}
{"content": "\n\n\n\n\n\n\n\n\nAlpharetta, GA, March  30, 2016  (GLOBE NEWSWIRE) -- FRONTLINE Selling has announced the release of Staccato PROTM, the next version of the ground-breaking B2B sales software and proven methodology that helps companies shorten the cold-call process, creating more sales opportunities and accelerating sales and revenue. \u00a0FRONTLINE Selling customers have reported as much as 200 to 400% increases in sales opportunities\u00a0when using this software and the new, enhanced version has features created to further the ROI even more.\u00a0 \u201cWe listened closely to the needs of our customers to create a product that provides the\u00a0features\u00a0to\u00a0take their sales efforts to new heights,\u201d commented Mike Scher, Co-Founder and CEO of FRONTLINE Selling. Mr. Sher developed Staccato as a way to duplicate his own sales process, which led him to an 18-year run on the President\u2019s Club, and validated it through the analysis of nearly 2 million outreach efforts. \u201cCompanies waste too much time in the prospect phase of the sale. The added functionalities of Staccato PROTM will bring in new customers, as well as help our existing clients be even more efficient, better trained and more successful at increasing the\u00a0number of opportunities to speak with key decision-makers.\u201d\u00a0 Staccato PROTM\u00a0features an intuitive UI and flexible pursuit models and scripts that provide high-level customization options. One of the most valuable features of Staccato PROTM is the inclusion of FRONTLINE\u2019s Gold Certification. This 90-day program includes an advanced, in-depth training on the Staccato methodology and software, objection handling, role playing and unlimited access to their unique Call Simulator, the cornerstone of their commitment to on-going training and reinforcement. The Certification also includes a component created solely to help sales managers fully understand key performance metrics, quickly identify problem areas in sales rep performance and ultimately Coach for Success. FRONTLINE is also releasing\u00a0a product add-on, Staccato Accelerator, which includes an integrated auto-dialer to improve sales efficiencies and an email analytics tool to gain unprecedented visibility into prospect email engagement. \u00a0\u201cStaccato PROTM\u00a0is the sales acceleration solution companies are desperately searching for to tap into unknown demand\u00a0and hit their aggressive revenue goals,\u201d added Ken Paskins, President and CRO of FRONTLINE. \u201cWe are confident this new product will have a dramatic impact on FRONTLINE\u2019s growth as well, allowing us to expand our global reach and bring this powerful SaaS solution to companies around the world.\u201d  # # #.gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} .gnwtablebottommargin {margin-bottom: 10.0px !important;} .gnwcellpaddingleft0 {padding-left: 0.0px !important;} .gnwverticalaligntop {vertical-align: top !important;} .gnwtextaligncenter {text-align: center !important;} .gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} .gnwverticalalignbottom {vertical-align: bottom !important;} .gnwwhitespacenowrap {white-space: nowrap !important;} .gnwtextalignright {text-align: right !important;} .gnwcellpaddingright0 {padding-right: 0.0px !important;} .gnwunderlinestyle {text-decoration: underline !important;} .gnwtextalignleft {text-align: left !important;} .gnw_ol {position: relative !important; left: 10px !important;} .gnw_ul {position: relative !important; left: 10px !important;} .gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} .gnw_border_top_solid {border-top: solid black 1px !important;} .gnw_border_right_solid {border-right: solid black 1px !important;} .gnw_border_bottom_solid {border-bottom: solid black 1px !important;} .gnw_border_left_solid {border-left: solid black 1px !important;} .gnw_border_top_double {border-top: double black 3px !important;} .gnw_border_right_double {border-right: double black 3px !important;} .gnw_border_bottom_double {border-bottom: double black 3px !important;} .gnw_border_left_double {border-left: double black 3px !important;} .gnw_table_border_collapse {border-collapse: collapse !important;} .gnw_align_left {text-align: left !important;} .gnw_align_center {text-align: center !important;} .gnw_align_right {text-align: right !important;} .gnw_align_justify {text-align: justify !important;} .gnw_vertical_align_top {vertical-align: top !important;} .gnw_vertical_align_middle {vertical-align: middle !important;} .gnw_vertical_align_bottom {vertical-align: bottom !important;} .gnw_padding_left_none {padding-left: 0 !important;} .gnw_padding_right_none {padding-right: 0 !important;} .gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} .gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} .gnw_heading {font: 16px Arial; text-align: center !important;} .gnw_subhead {font: 12px Arial; text-align: center !important;} .gnw_colhead {font: 12px Arial; text-align: center !important;} .gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} .gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} .gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} .gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} .gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} .gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} .gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} .gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} .gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} .gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} .gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} .gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} .gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} .gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} .gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} .gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} .gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} .gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} .gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} .gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} .gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} .gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} .gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} .gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} .gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} .gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} .gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} .gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} .gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} .gnw_media_bgcolor {background-color: transparent !important;} .gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} .gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} td.gnw_heading {font: 16px Arial; text-align: center !important;} td.gnw_subhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} td.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} td.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} td.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} td.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} td.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} td.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} td.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} td.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} ;}           \n\n\n                    Contact:\n                \n\nCarrol Van StoneVan Stone Publicity304-671-0244carrol@vanstonepublicity.com          \n\n\n\n", "title": "FRONTLINE Selling Releases Staccato PRO", "symbols": [], "link": "http://finance.yahoo.com/news/frontline-selling-releases-staccato-pro-140000708.html", "date": "7 hours ago", "_id": {"$oid": "56fc80f7fb1fdb5e35baa8f3"}, "nes": {"MONEY": ["# #"], "PERCENT": ["400%"], "PERSON": ["Ken Paskins", "Mike Scher", "Mr. Sher"], "LOCATION": ["Alpharetta", "Geneva", "Helvetica", "Verdana"], "DATE": ["March  30, 2016"], "ORGANIZATION": ["GA", "President\u2019s Club"]}}
{"content": "\n\n\n\n\n\n\n\n\nDALLAS, TX, March 30, 2016 (GLOBE NEWSWIRE) -- Meeting Professionals International (MPI) and host city partners Meet AC and Caesars Entertainment are committed to providing unique and exciting networking opportunities at this year's World Education Congress (WEC) in Atlantic City. MPI is offering a new registration option -- the WEC Networking Package -- that grants exclusive entry to all four evening events, including the MPI Foundation's Rendezvous which will be headlined by the Grammy(R) Award-winning band Train.\tIn addition, the association has created the Meeting Ambassador Program (MAP) to help attendees make the most of their WEC 2016 experience. MPI will pair up any interested attendee (mentee/explorer) who would like tips and advice for navigating the conference with a past WEC attendee (ambassador/navigator). The program includes the MAP Meet and Greet Reception, MAP Lounge and WEC For Me session. Attendees are encouraged to sign up early for the program during online registration.\t\"Year after year, attendees tell us how valuable WEC is for growing their professional networks,\" said Paul Van Deventer, president and CEO of MPI. \"We understand how critical networking is to the business of meeting and event planning, so we offer an array of opportunities for our attendees to connect. This year, we believe the new networking package will be especially popular with the supplier community.\"\tFollowing are more details on WEC 2016 evening networking events.\tOpening Night Celebration -- Attendees will sample exceptional cuisine from more than 20 local restaurants at the Bally's Atlantic City Beach Bar, located near the Atlantic Ocean. Hosted by Caesars Entertainment, this beach party is scheduled for 6:30-9:30 p.m. on Saturday, June 11th. Afterwards, WEC attendees may continue socializing from 10 p.m. to midnight at the iconic Steel Pier amusement park.\tThe Big Deal -- Presented by the MPI Foundation, this official World Series of Poker satellite tournament will take place on Sunday, June 12th from 9:00 p.m. to 1:00 a.m. in the Palladium Ballroom at Caesars Atlantic City. WEC attendees not playing in the tournament will enjoy networking, music, dancing, raffles, games and more thanks to presenting sponsors Caesars Entertainment and Encore Event Technologies.\tRendezvous -- This MPI Foundation signature networking and fundraising event is slated for Monday, June 13th from 9:00 p.m. to 1:00 a.m. at WAV, a new nightclub on Atlantic City's waterfront opening this spring at The Playground Pier at Caesars Atlantic City. The event will feature a performance by Train, the band best known for its popular singles, \"Hey, Soul Sister,\" \"Marry Me,\" and \"Drops of Jupiter (Tell Me).\" The presenting sponsors for Rendezvous are Meet AC and Team San Jose.\tClosing Night Celebration -- Hosted by Meet AC and Caesars Entertainment, this closing party will be held Tuesday, June 14th from 7 -- 10 p.m. at The Pool After Dark at Harrah's Resort Atlantic City. It will be deejayed by dance/pop music creator Redfoo of LMFAO.\t\"As your WEC host, Meet AC has worked very hard to enhance your social networking opportunities, while also experiencing Atlantic City to its fullest,\" said Jim Wood, president and CEO of Meet AC. \"As the industry continues to grow, the networking events are crucial to attend and connect with professionals on a personal level.\"\t\"Caesars Entertainment is thrilled to be hosting the Opening Night Celebration at Bally's Beach Bar, The Big Deal at Caesars Atlantic City and the Closing Night Celebration at The Pool After Dark at Harrah's. We're all in the business of face-to-face meetings, and we understand that networking with our peers is a valuable and inspiring experience. We've had the pleasure of being able to work with the city, and MEET AC, to coordinate these exciting opportunities for the attendees of WEC 2016 to network and connect,\" said Michael Massari, senior vice president of national meetings and events at Caesars Entertainment.\tAdditional opportunities for networking included in WEC 2016 full registration are an all-attendee lunch on Sunday, the RISE Awards Lunch on Monday, the WEC 2017 Preview Lunch on Tuesday, and MarketSquare and volunteer/corporate social responsibility (CSR) activities available throughout WEC.\tFunds raised from MPI Foundation events and the MPI Foundation Not-So-Silent Auction, which is open May 16 -- June 14, will be invested in scholarships, grants and pan-industry research. Last year, the foundation provided 230 scholarships, including 60 that helped MPI members attend WEC 2015.\tWEC 2016 is scheduled for June 11 -- 14, in Atlantic City, New Jersey. To learn more and register, visit www.mpiweb.org/wec16.\tAbout MPI\tMeeting Professionals International (MPI) is the largest and most vibrant global meeting and event industry association. The organization provides innovative and relevant education, networking opportunities and business exchanges, and acts as a prominent voice for the promotion and growth of the industry. MPI membership includes approximately 18,500 members belonging to more than 80 chapters and clubs in 22 countries. For additional information or to join, visit www.mpiweb.org..gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} .gnwtablebottommargin {margin-bottom: 10.0px !important;} .gnwcellpaddingleft0 {padding-left: 0.0px !important;} .gnwverticalaligntop {vertical-align: top !important;} .gnwtextaligncenter {text-align: center !important;} .gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} .gnwverticalalignbottom {vertical-align: bottom !important;} .gnwwhitespacenowrap {white-space: nowrap !important;} .gnwtextalignright {text-align: right !important;} .gnwcellpaddingright0 {padding-right: 0.0px !important;} .gnwunderlinestyle {text-decoration: underline !important;} .gnwtextalignleft {text-align: left !important;} .gnw_heading {font: 16px Arial; text-align: center !important;} .gnw_subhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; border-bottom: solid black 1.0pt;} td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} td.gnw_num          {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} td.gnw_data         {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_news_media_box  {float: left !important; margin: 6px !important; border: solid 1px #a9a9a9 !important; width: 250px !important;} .gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} .gnw_media_bgcolor {background-color: transparent !important;} .gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} .gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} .gnw_ol {position: relative !important; left: 10px !important;} .gnw_ul {position: relative !important; left: 10px !important;} .gnw_border_top_solid {border-top: solid black 1px !important;} .gnw_border_right_solid {border-right: solid black 1px !important;} .gnw_border_bottom_solid {border-bottom: solid black 1px !important;} .gnw_border_left_solid {border-left: solid black 1px !important;} .gnw_border_top_double {border-top: double black 3px !important;} .gnw_border_right_double {border-right: double black 3px !important;} .gnw_border_bottom_double {border-bottom: double black 3px !important;} .gnw_border_left_double {border-left: double black 3px !important;} .gnw_table_border_collapse {border-collapse: collapse !important;} .gnw_table_border_collapse td {padding-left: 3px !important; padding-right: 3px !important;} .gnw_align_left {text-align: left !important;} .gnw_align_center {text-align: center !important;} .gnw_align_right {text-align: right !important;} .gnw_align_justify {text-align: justify !important;} .gnw_vertical_align_top {vertical-align: top !important;} .gnw_vertical_align_middle {vertical-align: middle !important;} .gnw_vertical_align_bottom {vertical-align: bottom !important;} ;} Professional ServicesAtlantic CityCaesars Atlantic City\n\n\n                    Contact:\n                \n\nSonya Thorpe Cobbsthorpe@mpiweb.org\n\n\n\n", "title": "MPI Enhancing Networking Experience for World Education Congress 2016, Introduces Special Registration \u2026", "symbols": [], "link": "http://finance.yahoo.com/news/mpi-enhancing-networking-experience-world-135853301.html", "date": "7 hours ago", "_id": {"$oid": "56fc80f7fb1fdb5e35baa8f4"}, "nes": {"DATE": ["2016", "June 11", "June 12th", "June 13th", "June 14", "June 14th", "March 30, 2016", "May 16", "Monday", "Saturday, June 11th", "Sunday", "Tuesday", "spring"], "ORGANIZATION": ["AC", "Bally", "Caesars Entertainment", "Harrah", "Harrah's", "Jupiter", "MPI", "MPI Foundation", "Opening Night Celebration", "WAV", "WEC", "World Education Congress"], "PERSON": ["Jim Wood", "Michael Massari", "Paul Van Deventer", "Sonya Thorpe"], "LOCATION": ["Atlantic City", "Atlantic City Beach Bar", "Atlantic Ocean", "Caesars Atlantic City", "DALLAS", "Geneva", "Helvetica", "MAP Lounge", "New Jersey", "Palladium Ballroom", "Resort Atlantic City", "TX", "Verdana"], "TIME": ["10 p.m.", "10 p.m. to midnight", "1:00 a.m.", "6:30-9:30 p.m.", "9:00 p.m."]}}
{"content": "\n\n\n\n\n\n\nBOISE, Idaho, March  30, 2016  (GLOBE NEWSWIRE) -- Micron Technology, Inc., (MU) today announced results of operations for its second quarter of fiscal 2016, which ended March 3, 2016. Revenues for the second quarter of fiscal 2016 were $2.93 billion and were 12 percent lower compared to the first quarter of fiscal 2016 and 30 percent lower compared to the second quarter of fiscal 2015. Cash flows from operations were $763 million for the second quarter of fiscal 2016.\nGAAP Income and Per Share Data \u2013 On a GAAP(1) basis, net loss attributable to Micron shareholders for the second quarter of fiscal 2016 was $97 million, or ($0.09) per diluted share, compared to net income of $206 million, or $0.19 per diluted share, for the first quarter of fiscal 2016. Non-GAAP Income and Per Share Data \u2013 On a non-GAAP(2) basis, net loss attributable to Micron shareholders for the second quarter of fiscal 2016 was $48 million, or ($0.05) per diluted share, compared to net income of $249 million, or $0.24 per diluted share, for the first quarter of fiscal 2016. For a reconciliation of GAAP to non-GAAP results, see the accompanying financial tables and footnotes. \"Although we continue to navigate challenging market conditions, we are on track with deploying our advanced DRAM and NAND technologies and improving our cost structure,\" said Micron CEO Mark Durcan. \"As a result, we expect to significantly improve our competitive position as we move through the second half of 2016 and beyond.\" Revenues for the second quarter of fiscal 2016 were lower compared to the first quarter of fiscal 2016 primarily due to approximate 10 percent declines in both DRAM average selling prices and sales volume. Non-Volatile trade revenues for the second quarter of fiscal 2016 declined 6 percent compared to the first quarter primarily as a result of an approximate 15 percent decline in average selling prices partially offset by an increase in sales volume. The company's overall consolidated gross margin of 20 percent for the second quarter of fiscal 2016 was 5 percent lower compared to the first quarter of fiscal 2016 primarily due to lower average selling prices partially offset by manufacturing cost reductions for Non-Volatile products. Investments in capital expenditures for the second quarter of fiscal 2016 were $1.23 billion. The company ended the second quarter of fiscal 2016 with cash and marketable investments of $5.14 billion. The company will host a conference call Wednesday, March 30, 2016 at 2:30 p.m. MT to discuss its financial results. The call, audio, and slides will be available online at http://edge.media-server.com/m/p/336xx5th. A webcast replay will be available on the company's website until March 30, 2017. A taped audio replay of the conference call will also be available at 1-404-537-3406 or 1-855-859-2056 (conference number: 67709190) beginning at 5:30 p.m. MT, Wednesday, March 30, 2016 and continuing through Thursday, April 7, 2016. For Investor Relations and other company updates, follow @MicronTech on Twitter at https://twitter.com/MicronTech. Micron Technology, Inc., is a global leader in advanced semiconductor systems. Micron's broad portfolio of high-performance memory technologies\u2014including DRAM, NAND, and NOR Flash\u2014is the basis for solid state drives, modules, multichip packages, and other system solutions. Backed by more than 35 years of technology leadership,\u00a0Micron's memory solutions enable the world's most innovative computing, consumer, enterprise storage, networking, mobile, embedded, and automotive applications.\u00a0Micron's common stock is traded on the NASDAQ under the MU symbol. To learn more about Micron Technology, Inc., visit www.micron.com. (1) GAAP represents U.S. Generally Accepted Accounting Principles.(2) Non-GAAP represents GAAP excluding the impact of certain activities which the company's management excludes in analyzing the company's operating results and understanding trends in the company's earnings. Non-GAAP also includes the impact on shares used in per share calculations of the company's outstanding capped call transactions. For a reconciliation of GAAP to non-GAAP results, see the accompanying financial tables and footnotes. \u00a0MICRON TECHNOLOGY, INC.CONSOLIDATED FINANCIAL SUMMARY(in millions except per share amounts)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02nd Qtr.\u00a01st Qtr.\u00a02nd Qtr.\u00a0Six Months Ended\u00a0\u00a0March 3, \u00a02016\u00a0December 3, \u00a02015\u00a0March 5, \u00a02015\u00a0March 3, \u00a02016\u00a0March 5, \u00a02015Net sales\u00a0$2,934\u00a0\u00a0$3,350\u00a0\u00a0$4,166\u00a0\u00a0$6,284\u00a0\u00a0$8,739\u00a0Cost of goods sold\u00a02,355\u00a0\u00a02,501\u00a0\u00a02,761\u00a0\u00a04,856\u00a0\u00a05,696\u00a0Gross margin\u00a0579\u00a0\u00a0849\u00a0\u00a01,405\u00a0\u00a01,428\u00a0\u00a03,043\u00a0Selling, general, and administrative\u00a0175\u00a0\u00a0179\u00a0\u00a0187\u00a0\u00a0354\u00a0\u00a0380\u00a0Research and development\u00a0403\u00a0\u00a0421\u00a0\u00a0379\u00a0\u00a0824\u00a0\u00a0755\u00a0Other operating (income) expense, net\u00a06\u00a0\u00a017\u00a0\u00a0(16)\u00a023\u00a0\u00a0(32)Operating income (loss)\u00a0(5)\u00a0232\u00a0\u00a0855\u00a0\u00a0227\u00a0\u00a01,940\u00a0Interest income (expense), net\u00a0(85)\u00a0(85)\u00a0(75)\u00a0(170)\u00a0(158)Other non-operating income (expense), net (1)\u00a0(6)\u00a0(4)\u00a0(6)\u00a0(10)\u00a0(55)Income tax (provision) benefit (2)\u00a0(5)\u00a04\u00a0\u00a0(47)\u00a0(1)\u00a0(122)Equity in net income of equity method investees\u00a05\u00a0\u00a059\u00a0\u00a0208\u00a0\u00a064\u00a0\u00a0332\u00a0Net (income) loss attributable to noncontrolling interests\u00a0(1)\u00a0\u2014\u00a0\u00a0(1)\u00a0(1)\u00a0\u2014\u00a0Net income (loss) attributable to Micron\u00a0$(97)\u00a0$206\u00a0\u00a0$934\u00a0\u00a0$109\u00a0\u00a0$1,937\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Earnings (loss) per share:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Basic\u00a0$(0.09)\u00a0$0.20\u00a0\u00a0$0.87\u00a0\u00a0$0.11\u00a0\u00a0$1.81\u00a0Diluted\u00a0(0.09)\u00a00.19\u00a0\u00a00.78\u00a0\u00a00.10\u00a0\u00a01.62\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Number of shares used in per share calculations:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Basic\u00a01,036\u00a0\u00a01,035\u00a0\u00a01,074\u00a0\u00a01,035\u00a0\u00a01,072\u00a0Diluted\u00a01,036\u00a0\u00a01,085\u00a0\u00a01,190\u00a0\u00a01,072\u00a0\u00a01,193\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0CONSOLIDATED FINANCIAL SUMMARY, Continued\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0As of\u00a0March 3, \u00a02016\u00a0December 3, \u00a02015\u00a0September 3, \u00a02015Cash and short-term investments\u00a0$4,035\u00a0\u00a0$3,641\u00a0\u00a0$3,521\u00a0Receivables\u00a01,984\u00a0\u00a02,223\u00a0\u00a02,507\u00a0Inventories\u00a02,608\u00a0\u00a02,435\u00a0\u00a02,340\u00a0Total current assets\u00a08,805\u00a0\u00a08,510\u00a0\u00a08,596\u00a0Long-term marketable investments\u00a01,108\u00a0\u00a01,771\u00a0\u00a02,113\u00a0Property, plant, and equipment, net\u00a011,819\u00a0\u00a011,060\u00a0\u00a010,554\u00a0Total assets\u00a024,819\u00a0\u00a024,388\u00a0\u00a024,143\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Accounts payable and accrued expenses\u00a03,087\u00a0\u00a02,784\u00a0\u00a02,611\u00a0Current debt (1)(3)\u00a01,125\u00a0\u00a01,051\u00a0\u00a01,089\u00a0Total current liabilities\u00a04,411\u00a0\u00a04,025\u00a0\u00a03,905\u00a0Long-term debt (1)(3)\u00a06,494\u00a0\u00a06,326\u00a0\u00a06,252\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Total Micron shareholders' equity\u00a012,264\u00a0\u00a012,301\u00a0\u00a012,302\u00a0Noncontrolling interests in subsidiaries\u00a0975\u00a0\u00a0974\u00a0\u00a0937\u00a0Total equity\u00a013,239\u00a0\u00a013,275\u00a0\u00a013,239\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0Six Months Ended\u00a0\u00a0March 3, \u00a02016\u00a0March 5, \u00a02015Net cash provided by operating activities\u00a0$1,883\u00a0\u00a0$2,843\u00a0Net cash provided by (used for) investing activities\u00a0(1,026)\u00a0(3,202)Net cash provided by (used for) financing activities\u00a0(68)\u00a0(144)\u00a0\u00a0\u00a0\u00a0\u00a0Depreciation and amortization\u00a01,575\u00a0\u00a01,355\u00a0Expenditures for property, plant, and equipment\u00a0(2,209)\u00a0(1,522)Repayments of debt\u00a0(519)\u00a0(1,149)Proceeds from issuance of debt\u00a0598\u00a0\u00a01,254\u00a0Cash paid to acquire treasury stock\u00a0(147)\u00a0(244)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0(1) Other non-operating income (expense) consisted of the following: \u00a0\u00a02nd Qtr.\u00a01st Qtr.\u00a02nd Qtr.\u00a0Six Months Ended\u00a0\u00a0March 3, \u00a02016\u00a0December 3, \u00a02015\u00a0March 5, \u00a02015\u00a0March 3, \u00a02016\u00a0March 5, \u00a02015Loss from changes in currency exchange rates\u00a0$(5)\u00a0$(3)\u00a0$(6)\u00a0$(8)\u00a0$(27)Loss on restructure of debt\u00a0\u2014\u00a0\u00a0(1)\u00a0\u2014\u00a0\u00a0(1)\u00a0(30)Other\u00a0(1)\u00a0\u2014\u00a0\u00a0\u2014\u00a0\u00a0(1)\u00a02\u00a0\u00a0\u00a0$(6)\u00a0$(4)\u00a0$(6)\u00a0$(10)\u00a0$(55)During the first quarter of fiscal 2016, the company recognized a loss of $1 million on the repurchase of $57 million in aggregate principal amount of 2033E Notes for $94 million in cash. In the first six months of fiscal 2015, the company recognized losses of $30 million from transactions to restructure its debt, including conversions, settlements and repurchases of convertible notes, and the early repayment of a note. (2) Income taxes included a provision related to changes in amounts of net deferred tax assets associated with the company's MMJ and MMT operations of $10 million for the second quarter of fiscal 2016, $22 million for the first quarter of fiscal 2016, and $33 million for the second quarter of fiscal 2015. Income taxes for the first quarter of fiscal 2016 also included a benefit of $41 million from business acquisition activities. Remaining taxes for fiscal 2016 and 2015 primarily reflect taxes on the company's other non-U.S. operations. The company has a full valuation allowance for its net deferred tax asset associated with its U.S. operations. Income taxes on U.S. operations for fiscal 2016 and 2015 were substantially offset by changes in the valuation allowance. (3) In the second quarter of fiscal 2016, the company recorded capital lease obligations aggregating $424 million related to equipment sale-leaseback transactions at a weighted-average effective interest rate of 2.7%, payable in periodic installments through December 2020. In the first quarter of fiscal 2016, the company drew the remaining $174 million of financing under a term loan agreement, collateralized by certain property, plant, and equipment. \u00a0MICRON TECHNOLOGY, INC.RECONCILIATION OF GAAP TO NON-GAAP RESULTS(in millions except per share amounts)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02nd Qtr.\u00a01st Qtr.\u00a0\u00a0\u00a0\u00a0March 3, \u00a02016\u00a0December 3, \u00a02015GAAP net income (loss) attributable to Micron\u00a0\u00a0\u00a0$(97)\u00a0$206\u00a0Non-GAAP adjustments:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Restructure and asset impairments\u00a0\u00a0\u00a01\u00a0\u00a015\u00a0Amortization of debt discount and other costs\u00a0\u00a0\u00a031\u00a0\u00a033\u00a0Loss on restructure of debt\u00a0\u00a0\u00a0\u2014\u00a0\u00a01\u00a0(Gain) loss from changes in currency exchange rates\u00a0\u00a0\u00a05\u00a0\u00a03\u00a0Estimated tax effects of above items\u00a0\u00a0\u00a0(1)\u00a02\u00a0Non-cash taxes from MMJ, MMT, and Inotera\u00a0\u00a0\u00a013\u00a0\u00a030\u00a0Non-cash taxes from business acquisition activities\u00a0\u00a0\u00a0\u2014\u00a0\u00a0(41)Total non-GAAP adjustments\u00a0\u00a0\u00a049\u00a0\u00a043\u00a0Non-GAAP net income (loss) attributable to Micron\u00a0\u00a0\u00a0$(48)\u00a0$249\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Number of shares used in diluted per share calculations:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0GAAP\u00a0\u00a0\u00a01,036\u00a0\u00a01,085\u00a0Effect of capped calls\u00a0\u00a0\u00a0\u2014\u00a0\u00a0(50)Non-GAAP\u00a0\u00a0\u00a01,036\u00a0\u00a01,035\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Diluted earnings (loss) per share:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0GAAP\u00a0\u00a0\u00a0$(0.09)\u00a0$0.19\u00a0Effects of above\u00a0\u00a0\u00a00.04\u00a0\u00a00.05\u00a0Non-GAAP\u00a0\u00a0\u00a0$(0.05)\u00a0$0.24\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The table above sets forth non-GAAP net income (loss) attributable to Micron, diluted shares and diluted earnings (loss) per share. The adjustments above may or may not be infrequent or nonrecurring in nature but are a result of periodic or non-core operating activities of the company. The company believes this non-GAAP information is helpful to understanding trends and in analyzing the company's operating results and earnings. The company is providing this information to investors to assist in performing analyses of the company's operating results. When evaluating performance and making decisions on how to allocate company resources, management uses this non-GAAP information and believes investors should have access to similar data when making their investment decisions. The presentation of these adjusted amounts vary from numbers presented in accordance with U.S. GAAP and therefore may not be comparable to amounts reported by other companies. The company's management excludes the following items in analyzing the company's operating results and understanding trends in the company's earnings: Restructure and asset impairments;Amortization of debt discount and other costs, including the accretion of non-cash interest expense associated with the company's convertible debt and the MMJ installment debt;Loss on restructure of debt;(Gain) loss from changes in currency exchange rates;The estimated tax effects of above items; Non-cash taxes resulting from utilization of, and other changes in, deferred tax assets of MMJ, MMT, and Inotera (an equity method investment of the company); andNon-cash taxes resulting from business acquisition activities.Non-GAAP diluted shares include the impact of the company's outstanding capped call transactions, which are anti-dilutive in GAAP earnings per share but are expected to mitigate the dilutive effect of the company's convertible notes. The anti-dilutive effect of the capped calls is based on the average share price for the period the capped calls are outstanding during the quarter. .gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} \n.gnwtablebottommargin {margin-bottom: 10.0px !important;} \n.gnwcellpaddingleft0 {padding-left: 0.0px !important;} \n.gnwverticalaligntop {vertical-align: top !important;} \n.gnwtextaligncenter {text-align: center !important;} \n.gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} \n.gnwverticalalignbottom {vertical-align: bottom !important;} \n.gnwwhitespacenowrap {white-space: nowrap !important;} \n.gnwtextalignright {text-align: right !important;} \n.gnwcellpaddingright0 {padding-right: 0.0px !important;} \n.gnwunderlinestyle {text-decoration: underline !important;} \n.gnwtextalignleft {text-align: left !important;} \n.gnw_ol {position: relative !important; left: 10px !important;} \n.gnw_ul {position: relative !important; left: 10px !important;} \n.gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} \n.gnw_border_top_solid {border-top: solid black 1px !important;} \n.gnw_border_right_solid {border-right: solid black 1px !important;} \n.gnw_border_bottom_solid {border-bottom: solid black 1px !important;} \n.gnw_border_left_solid {border-left: solid black 1px !important;} \n.gnw_border_top_double {border-top: double black 3px !important;} \n.gnw_border_right_double {border-right: double black 3px !important;} \n.gnw_border_bottom_double {border-bottom: double black 3px !important;} \n.gnw_border_left_double {border-left: double black 3px !important;} \n.gnw_table_border_collapse {border-collapse: collapse !important;} \n.gnw_align_left {text-align: left !important;} \n.gnw_align_center {text-align: center !important;} \n.gnw_align_right {text-align: right !important;} \n.gnw_align_justify {text-align: justify !important;} \n.gnw_vertical_align_top {vertical-align: top !important;} \n.gnw_vertical_align_middle {vertical-align: middle !important;} \n.gnw_vertical_align_bottom {vertical-align: bottom !important;} \n.gnw_padding_left_none {padding-left: 0 !important;} \n.gnw_padding_right_none {padding-right: 0 !important;} \n.gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} \n.gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} \n.gnw_heading {font: 16px Arial; text-align: center !important;} \n.gnw_subhead {font: 12px Arial; text-align: center !important;} \n.gnw_colhead {font: 12px Arial; text-align: center !important;} \n.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} \n.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} \n.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} \n.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \n.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} \n.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} \n.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} \n.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} \n.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} \n.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} \n.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} \n.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} \n.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} \n.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} \n.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} \n.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \n.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} \n.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} \n.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} \n.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} \n.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} \n.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} \n.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} \n.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} \n.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} \n.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} \n.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} \n.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \n.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \n.gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} \n.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} \n.gnw_media_bgcolor {background-color: transparent !important;} \n.gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} \n.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} \ntd.gnw_heading {font: 16px Arial; text-align: center !important;} \ntd.gnw_subhead {font: 12px Arial; text-align: center !important;} \ntd.gnw_colhead {font: 12px Arial; text-align: center !important;} \ntd.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} \ntd.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} \ntd.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} \ntd.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \ntd.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} \ntd.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} \ntd.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} \ntd.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} \ntd.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} \ntd.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} \ntd.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} \ntd.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} \ntd.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} \ntd.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} \ntd.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} \ntd.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \ntd.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} \ntd.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} \ntd.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} \ntd.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} \ntd.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} \ntd.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} \ntd.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} \ntd.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} \ntd.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} \ntd.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} \ntd.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} \ntd.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \ntd.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \ntd.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} \ntd.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} \n;} \n\n          \nMicron\n\n\n                    Contact:\n                \n\nContacts:\tIvan DonaldsonInvestor Relationsidonaldson@micron.com(208) 368-4093Daniel FranciscoMedia Relationsdfrancisco@micron.com(208) 368-5584          \n\n\n\n", "title": "Micron Technology, Inc., Reports Results for the Second Quarter of Fiscal 2016", "symbols": ["MU"], "link": "http://finance.yahoo.com/news/micron-technology-inc-reports-results-200611443.html", "date": "54 minutes ago", "_id": {"$oid": "56fc80fcfb1fdb5e34baa8f0"}, "nes": {"MONEY": ["$", "$0.05", "$0.09", "$0.19", "$0.20\u00a0\u00a0$0.87\u00a0\u00a0$0.11\u00a0\u00a0$1.81", "$0.24", "$1 million", "$1,883\u00a0\u00a0$2,843", "$1.23 billion", "$10 million", "$174 million", "$2,934\u00a0\u00a0$3,350\u00a0\u00a0$4,166\u00a0\u00a0$6,284\u00a0\u00a0$8,739", "$2.93 billion", "$206", "$206 million", "$206\u00a0\u00a0$934\u00a0\u00a0$109\u00a0\u00a0$1,937", "$22 million", "$249", "$249 million", "$30 million", "$33 million", "$4,035\u00a0\u00a0$3,641\u00a0\u00a0$3,521", "$41 million", "$424 million", "$48 million", "$5.14 billion", "$57 million", "$763 million", "$94 million", "$97 million"], "PERCENT": ["10 percent", "12 percent", "15 percent", "2.7%", "20 percent", "30 percent", "5 percent", "6 percent"], "PERSON": ["Daniel FranciscoMedia", "Ivan DonaldsonInvestor", "Mark Durcan"], "LOCATION": ["BOISE", "Geneva", "Helvetica", "Idaho", "U.S.", "Verdana"], "TIME": ["2:30 p.m.", "5:30 p.m. MT"], "DATE": ["2015", "2016", "April 7, 2016", "December 2020", "March  30, 2016", "March 3, 2016", "March 3, \u00a02016\u00a0December 3", "March 3, \u00a02016\u00a0December 3, \u00a02015\u00a0March 5, \u00a02015\u00a0March 3, \u00a02016\u00a0March 5", "March 3, \u00a02016\u00a0December 3, \u00a02015\u00a0September 3", "March 3, \u00a02016\u00a0March 5", "March 30, 2016", "March 30, 2017", "Thursday", "Wednesday", "first quarter", "first quarter of fiscal 2016", "first six months of fiscal 2015", "second half of 2016", "second quarter of fiscal 2015", "second quarter of fiscal 2016"], "ORGANIZATION": ["GAAP", "MMJ", "MMT", "Micron", "Micron Technology, Inc.", "NASDAQ", "Per Share Data"]}}
{"content": "\n\n\n\n\n\n\nWHITE PLAINS, N.Y., March  30, 2016  (GLOBE NEWSWIRE) -- SPAR Group, Inc. (SGRP), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced financial results for the fourth quarter and year ended December 31, 2015.\nHighlights for the three and twelve month periods ended December 31, 2015, as compared to the same periods in the prior year include: Revenue for the fourth quarter of 2015 increased 0.7 percent to $32.3 million.\u00a0 Adjusting for the impact of foreign currency translation, revenue for the fourth quarter of 2015 increased $3.7 million, or 11.6 percent.Net income attributable to SPAR Group for the fourth quarter of 2015 was $1.0 million, or $0.05 per diluted share, compared to $2.7 million, or $0.12 per diluted share, during the fourth quarter of 2014.\u00a0 Net income for the prior year period included a positive contribution of $1.9 million or $0.09 per diluted share related to the release of a deferred tax asset valuation allowance.\u00a0Revenue for the fiscal year 2015 decreased 2.2 percent to $119.3 million.\u00a0 Adjusting for the impact of foreign currency translation, revenue for the fiscal year 2015 increased $7.5 million or 6.1 percent.Net income attributable to SPAR Group for the fiscal year 2015 was $892,000, or $0.04 per diluted share, compared to net income of $3.3 million, or $0.15 per diluted share for the fiscal year 2014.\u00a0 Net income for the prior year period included a positive contribution of $1.9 million or $0.09 per diluted share related to the release of a deferred tax asset valuation allowance.Financial Results by Geography (in 000's) \u00a0Three Months Ended December 31,\u00a0 %\u00a0Twelve Months Ended December 31,%Revenue:\u00a02015\u00a0\u00a0\u00a02014\u00a0\u00a0 Change\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0ChangeInternational \u00a0 \u00a0 \u00a0 \u00a0$\u00a0 21,448\u00a0\u00a0$\u00a0 20,912\u00a0\u00a02.6%\u00a0$\u00a0 75,667\u00a0\u00a0$\u00a0 75,617\u00a0\u00a00.1%Domestic\u00a0\u00a0 10,828\u00a0\u00a0\u00a0\u00a0 11,140\u00a0\u00a0(2.8)%\u00a0\u00a0\u00a0 43,612\u00a0\u00a0\u00a0\u00a0 46,404\u00a0\u00a0(6.0)%Total$\u00a0 32,276\u00a0\u00a0$\u00a0 32,052 \u00a0\u00a0 \u00a00.7%\u00a0$\u00a0 119,279\u00a0\u00a0$\u00a0 122,021 \u00a0\u00a0(2.2)% \u00a0Three Months Ended December 31,\u00a0\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Twelve Months Ended December 31,\u00a0\u00a0Net Income:\u00a02015\u00a0\u00a0\u00a02014\u00a0\u00a0\u00a0 \u00a0 \u00a0 \u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0\u00a0\u00a0International$\u00a0 877\u00a0\u00a0$\u00a0 536\u00a0\u00a0\u00a0$\u00a0 505\u00a0\u00a0$\u00a0 628\u00a0\u00a0\u00a0Domestic\u00a0\u00a0 151\u00a0\u00a0\u00a0\u00a0 2,142\u00a0\u00a0\u00a0\u00a0\u00a0 387\u00a0\u00a0\u00a0\u00a0 2,640\u00a0\u00a0\u00a0Total$\u00a0 1,028\u00a0\u00a0$\u00a0 2,678\u00a0\u00a0\u00a0$\u00a0 892\u00a0\u00a0$\u00a0 3,268\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Earnings Per Share:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Basic$0.05\u00a0\u00a0$0.13\u00a0\u00a0\u00a0$0.04\u00a0\u00a0$0.16\u00a0\u00a0\u00a0Diluted:$0.05\u00a0\u00a0$0.12\u00a0\u00a0\u00a0$0.04\u00a0\u00a0$0.15\u00a0\u00a0\u00a0\"Our financial performance for 2015 was a mix of strength in those geographies and business units where we have put in place new strategic initiatives, offset by weakness in areas where we have yet to implement change.\u00a0 In addition, positive sales and profit comparisons from acquisitive growth in China and strong performance in South Africa and Mexico were masked by the strength of the U.S. dollar relative to other currencies,\" commented Chief Executive Officer, Jill Blanchard. \"While our performance has been inconsistent across geographies and business units, importantly we are having success in becoming a value partner to our clients and adding new global customers in late 2015, which will be incremental to revenue in the current year.\u00a0 Finally, we took our foot off of the accelerator in terms of investment in domestic business development.\u00a0 We expect this to stabilize profitability while allowing for modest growth with existing and new domestic customers.\u00a0 Overall, I\u2019m encouraged that we have put in place the right strategic initiatives that will allow for more consistent financial performance in 2016 and beyond.\u201d Margin Profile by Geography Gross Margin:  \u00a0Three Months Ended December 31,BasisPoint\u00a0Twelve Months Ended December 31,Basis Point\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0Change\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0ChangeInternational\u00a023.4%\u00a0\u00a025.2%\u00a0(178)\u00a0\u00a0\u00a0\u00a020.7%\u00a0\u00a020.8%\u00a0(6)\u00a0\u00a0Domestic\u00a031.8%\u00a0\u00a034.5%\u00a0(269)\u00a0\u00a0\u00a0\u00a031.1%\u00a0\u00a031.5%\u00a0(40)\u00a0\u00a0Total\u00a026.2%\u00a0\u00a028.4%\u00a0(220)\u00a0\u00a0\u00a0\u00a024.5%\u00a0\u00a024.9%\u00a0(34)\u00a0\u00a0Operating Expenses as a % of Sales: \u00a0Three Months Ended December 31,BasisPoint\u00a0Twelve Months Ended December 31,Basis Point\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0Change\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0ChangeInternational\u00a014.7%\u00a0\u00a018.8%\u00a0(411)\u00a0\u00a0\u00a0\u00a017.2%\u00a0\u00a018.2%\u00a0(100)\u00a0\u00a0Domestic\u00a029.0%\u00a0\u00a030.0%\u00a0(100)\u00a0\u00a0\u00a0\u00a029.7%\u00a0\u00a028.6%\u00a0111\u00a0\u00a0\u00a0Total\u00a019.5%\u00a0\u00a022.7%\u00a0(320)\u00a0\u00a0\u00a0\u00a021.8%\u00a0\u00a022.2%\u00a0(38)\u00a0\u00a0International gross profit margin for the fourth quarter of 2015 was 23.4% compared to 25.2% for the same period last year.\u00a0 The gross margin change relative to the prior period was primarily due to a mix of higher cost business in China, Mexico and Japan, partially offset by a mix of lower cost business in India, Australia, South Africa and Canada.\u00a0 International gross profit margin for the fiscal year 2015 was relatively unchanged year over year at 20.7%. Domestic gross profit margin for the three months ended December 31, 2015, was 31.8% compared to 34.5% for the same period in 2014. The decrease in gross profit margin was primarily due to an unfavorable mix of project work compared to the same period last year.\u00a0 Domestic gross profit margin for the fiscal year 2015 was 31.1% compared to 31.5% for the prior year. International operating income for fourth quarter of 2015 was $1.9 million, a 40 percent increase compared to $1.3 million during the same period in 2014.\u00a0 For fiscal 2015, international operating income was $2.7 million, a 37 percent increase from the prior year.\u00a0 International operating profit benefited from increased volume growth and the positive effect of foreign exchange on expenses. Domestic operating income for the fourth quarter of 2015 was $301,000, versus $498,000 during the fourth quarter of 2014.\u00a0 For the fiscal year 2015, domestic operating income was $609,000, compared to $1.3 million during fiscal year 2015.\u00a0 The increase in domestic operating expense margin for the twelve month period ended December 31, 2015 compared to last year is primarily attributable to lower sales volumes. Balance Sheet as of December 31, 2015 As of December 31, 2015, cash and cash equivalents totaled $5.7 million. Working capital was $16.8 million and current ratio was 2.3 to 1. Total current assets and total assets were $30.1 million and $43.4 million, respectively.\u00a0 Total current liabilities and total liabilities were $13.3 million and $19.0 million respectively, total equity was $24.4 million as of December 31, 2015. Recorded Comments Available Following the issuance of this release, the Company will provide recorded comments that can be accessed on the SPAR Group website under the \"Investor Relations\" section. http://investors.sparinc.com/releases.cfm About SPAR Group SPAR Group, Inc. is a diversified international merchandising and marketing services Company and provides a broad array of services worldwide to help companies improve their sales, operating efficiency and profits at retail locations. The Company provides merchandising and other marketing services to manufacturers, distributors and retailers worldwide, primarily in mass merchandiser, office supply, value, grocery, drug, independent, convenience, toy, home improvement and electronics stores, as well as providing furniture and other product assembly services, audit services, in-store events, technology services and marketing research. The Company has supplied these project and product services in the United States since certain of its predecessors were formed in 1979 and internationally since the Company acquired its first international subsidiary in Japan in May of 2001. Product services include restocking and adding new products, removing spoiled or outdated products, resetting categories \"on the shelf\" in accordance with client or store schematics, confirming and replacing shelf tags, setting new sale or promotional product displays and advertising, replenishing kiosks, providing in-store event staffing and providing assembly services in stores, homes and offices. Audit services include price audits, point of sale audits, out of stock audits, intercept surveys and planogram audits. Other merchandising services include whole store or departmental product sets or resets (including new store openings), new product launches, in-store demonstrations, special seasonal or promotional merchandising, focused product support and product recalls. The Company currently does business in 9 countries that encompass approximately 50% of the total world population through its operations in the United States, Canada, Japan, South Africa, India, China, Australia, Mexico and Turkey.\u00a0For more information, please visit the SPAR Group's website at http://www.sparinc.com. Forward-Looking Statements This Press Release contains and the above referenced recorded comments will contain \"forward-looking statements\" made by SPAR Group, Inc. (\"SGRP\", and together with its subsidiaries, the \"SPAR Group\" or the \"Company\"), will be filed shortly in a Current Report on Form 8-K by SGRP with the Securities and Exchange Commission (the \"SEC\"). There also are \"forward looking statements\" contained in SGRP's Annual Report on Form 10-K for the year ended December 31, 2015 (the \"Annual Report\"), which will be filed shortly by SGRP with the SEC, SGRP's definitive Proxy Statement respecting its Annual Meeting of Stockholders to be held on or about May 19, 2016 (the \"Proxy Statement\"), which SGRP expects to file with the SEC on or about April 25, 2016, and SGRP's Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports and statements as and when filed with the SEC (including the Annual Report and the Proxy Statement, each a \"SEC Report\"). \"Forward-looking statements\" are defined in Section 27A of the Securities Act of 1933, as amended (the \"Securities Act\") and Section 21E of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and other applicable federal and state securities laws, rules and regulations, as amended (together with the Securities Act and Exchange Act, collectively, \"Securities Laws\"). The forward-looking statements made by the Company in this Press Release may include (without limitation) any expectations, guidance or other information respecting the pursuit or achievement of the Company's corporate strategic objectives (growth, customer value, employee development, productivity & efficiency, and earnings per share), building upon the Company's strong foundation, leveraging compatible global opportunities, improving on the value we already deliver to customers, our growing client base, continuing balance sheet strength, customer contract expansion, growing revenues and becoming profitable through organic growth and acquisitions, attracting new business that will increase SPAR Group's revenues, improving product mix, continuing to maintain or reduce costs or consummating any transactions. The Company's forward-looking statements also include, in particular and without limitation, those made in \"Business\", \"Risk Factors\" and \"Management's Discussion and Analysis of Financial Condition and Results of Operations\" in the Annual Report. You can identify forward-looking statements in such information by the Company's use of terms such as \"may\", \"will\", \"expect\", \"intend\", \"believe\", \"estimate\", \"anticipate\", \"continue\" or similar words or variations or negatives of those words. You should carefully consider (and not place undue reliance on) the Company's forward-looking statements, risk factors and the other risks, cautions and information made, contained or noted in or incorporated by reference into this Press Release, the Proxy Statement and the other applicable SEC Reports that could cause the Company's actual performance or condition (including its assets, business, capital, cash flow, credit, expenses, financial condition, income, liabilities, liquidity, locations, marketing, operations, performance, prospects, sales, strategies, taxation or other achievement, results, risks, trends or condition) to differ materially from the performance or condition planned, intended, anticipated, estimated or otherwise expected by the Company (collectively, \"expectations\") and described in the information in the Company's forward-looking and other statements, whether express or implied. Although the Company believes them to be reasonable, those expectations involve known and unknown risks, uncertainties and other unpredictable factors (many of which are beyond the Company's control) that could cause those expectations to fail to occur or be realized or such actual performance or condition to be materially and adversely different from the Company's expectations. In addition, new risks and uncertainties arise from time to time, and it is impossible for the Company to predict these matters or how they may arise or affect the Company. Accordingly, the Company cannot assure you that its expectations will be achieved in whole or in part, that the Company has identified all potential risks, or that the Company can successfully avoid or mitigate such risks in whole or in part, any of which could be significant and materially adverse to the Company and the value of your investment in SGRP's Common Stock. You should carefully review the risk factors described in the Annual Report (See Item 1A \u2013 Risk Factors) and any other risks, cautions or information made, contained or noted in or incorporated by reference into the Annual Report, the Proxy Statement or other applicable SEC Report. All forward-looking and other statements or information attributable to the Company or persons acting on its behalf are expressly subject to and qualified by all such risk factors and other risks, cautions and information. The Company does not intend or promise, and the Company expressly disclaims any obligation, to publicly update or revise any forward-looking statements, risk factors or other risks, cautions or information (in whole or in part), whether as a result of new information, risks or uncertainties, future events or recognition or otherwise, except as and to the extent required by applicable law.\u00a0  SPAR Group, Inc. and SubsidiariesConsolidated Statements of Income and Comprehensive Income (Loss)\u00a0(In thousands, except share and per share data) \u00a0Three Months Ended December 31,\u00a0Twelve Months Ended December 31,\u00a0\u00a02015\u00a0\u00a02014\u00a0\u00a0\u00a02015\u00a0\u00a02014\u00a0\u00a0 Net revenues$\u00a0 32,276\u00a0$\u00a0 32,052\u00a0\u00a0$119,279\u00a0$122,021\u00a0Cost of revenues\u00a023,808\u00a0\u00a022,938\u00a0\u00a0\u00a090,015\u00a0\u00a091,671\u00a0Gross profit\u00a08,468\u00a0\u00a09,114\u00a0\u00a0\u00a029,264\u00a0\u00a030,350\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Selling, general and administrative expenses\u00a05,805\u00a0\u00a06,786\u00a0\u00a0\u00a024,094\u00a0\u00a025,308\u00a0Depreciation and amortization\u00a0491\u00a0\u00a0493\u00a0\u00a0\u00a01,905\u00a0\u00a01,753\u00a0Operating income\u00a02,172\u00a0\u00a01,835\u00a0\u00a0\u00a03,265\u00a0\u00a03,289\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Interest expense\u00a027\u00a0\u00a030\u00a0\u00a0\u00a0214\u00a0\u00a0158\u00a0Other income, net\u00a0(175)\u00a0(90)\u00a0\u00a0(243)\u00a0(292)Income before income tax expense\u00a02,320\u00a0\u00a01,895\u00a0\u00a0\u00a03,294\u00a0\u00a03,423\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Income tax expense (benefit)\u00a0385\u00a0\u00a0(1,321)\u00a0\u00a0819\u00a0\u00a0(948)Net income\u00a01,935\u00a0\u00a03,216\u00a0\u00a0\u00a02,475\u00a0\u00a04,371\u00a0Net income attributable to non-controlling interest\u00a0(907)\u00a0(538)\u00a0\u00a0(1,583)\u00a0(1,103)Net income attributable to SPAR Group, Inc.$\u00a0 1,028\u00a0$\u00a0 2,678\u00a0\u00a0$\u00a0 892\u00a0$\u00a0 3,268\u00a0Basic income per common share:$\u00a0 0.05\u00a0$\u00a0 0.13\u00a0\u00a0$\u00a0 \u00a0 0.04\u00a0$\u00a0 0.16\u00a0\u00a0 Diluted income per common share:$\u00a0 0.05\u00a0$\u00a0 0.12\u00a0\u00a0$\u00a0 \u00a0 0.04\u00a0$\u00a0 0.15\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Weighted average common shares \u2013 basic\u00a020,551\u00a0\u00a020,558\u00a0\u00a0\u00a020,559\u00a0\u00a020,578\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Weighted average common shares \u2013 diluted\u00a021,546\u00a0\u00a021,743\u00a0\u00a0\u00a021,573\u00a0\u00a021,830\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Net income$\u00a0 1,935\u00a0$\u00a0 3,216\u00a0\u00a0$\u00a0 2,475\u00a0$\u00a0 4,371\u00a0Other comprehensive income (loss):\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Foreign currency translation adjustments\u00a0100\u00a0\u00a0(147)\u00a0\u00a0(1,313)\u00a0(525)Comprehensive income\u00a0\u00a0 \u00a02,035\u00a0\u00a0\u00a0 3,069\u00a0\u00a0\u00a0\u00a0 \u00a01,162\u00a0\u00a0\u00a0 3,846\u00a0Comprehensive loss attributable to non-controlling interest\u00a0(907)\u00a0(538)\u00a0\u00a0(1,583)\u00a0(1,103)Comprehensive income (loss) attributable to SPAR Group, Inc.$\u00a0 1,128\u00a0$\u00a0 2,531\u00a0\u00a0$\u00a0 (421)$\u00a0 2,743\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPAR Group, Inc. and SubsidiariesConsolidated Balance Sheets(In thousands, except share and per share data) \u00a0December 31, 2015December 31,  2014Assets\u00a0\u00a0Current assets:\u00a0\u00a0Cash and cash equivalents$\u00a0 \u00a0 5,718\u00a0\u00a0$\u00a0 4,382\u00a0Accounts receivable, net\u00a023,203\u00a0\u00a0\u00a026,245\u00a0Deferred income taxes\u00a0529\u00a0\u00a0\u00a0464\u00a0Prepaid expenses and other current assets\u00a0661\u00a0\u00a0\u00a0868\u00a0Total current assets\u00a030,111\u00a0\u00a0\u00a031,959\u00a0\u00a0 Property and equipment, net\u00a02,443\u00a0\u00a0\u00a02,175\u00a0Goodwill\u00a01,800\u00a0\u00a0\u00a01,800\u00a0Intangible assets, net\u00a02,551\u00a0\u00a0\u00a03,149\u00a0Deferred income taxes\u00a0\u00a05,890\u00a0\u00a0\u00a05,134\u00a0Other assets\u00a0611\u00a0\u00a0\u00a0353\u00a0Total assets$\u00a0 43,406\u00a0\u00a0$\u00a0 44,570\u00a0\u00a0Liabilities and equity\u00a0\u00a0Current liabilities:\u00a0\u00a0Accounts payable$\u00a0 2,984\u00a0\u00a0$\u00a0 4,011\u00a0Accrued expenses and other current liabilities\u00a07,082\u00a0\u00a0\u00a08,149\u00a0Accrued expenses due to affiliates\u00a078\u00a0\u00a0\u00a0487\u00a0Deferred income taxes\u00a0\u00a02,154\u00a0\u00a0\u00a01,540\u00a0Customer deposits\u00a0503\u00a0\u00a0\u00a0659\u00a0Lines of credit and short-term loans\u00a0476\u00a0\u00a0\u00a0658\u00a0Total current liabilities\u00a013,277\u00a0\u00a0\u00a015,504\u00a0Long-term debt and other liabilities\u00a05,731\u00a0\u00a0\u00a05,855\u00a0Total liabilities\u00a019,008\u00a0\u00a0\u00a021,359\u00a0\u00a0\u00a0\u00a0Equity:\u00a0\u00a0SPAR Group, Inc. equity\u00a0\u00a0Preferred stock, $.01 par value:\u00a0\u00a0Authorized and available shares\u2013 2,445,598\u00a0\u00a0Issued and outstanding shares\u2013\u00a0\u00a0None \u2013\u00a0 December 31, 2015 and December 31, 2014 \u00a0\u2013 \u00a0 \u00a0\u2013 \u00a0 \u00a0Common stock, $.01 par value:\u00a0\u00a0Authorized shares \u2013 47,000,000\u00a0\u00a0Issued shares \u2013\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a020,680,717 \u2013\u00a0 December 31, 2015 and December 31, 2014\u00a0207\u00a0\u00a0\u00a0207\u00a0Treasury stock, at cost \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0119,695 shares \u2013\u00a0 December 31, 2015 and\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0121,663 shares \u2013\u00a0 December 31, 2014\u00a0(169)\u00a0\u00a0(183)Additional paid-in capital\u00a015,871\u00a0\u00a0\u00a015,519\u00a0Accumulated other comprehensive loss\u00a0(2,869)\u00a0\u00a0(1,556)Retained earnings\u00a05,662\u00a0\u00a0\u00a04,770\u00a0Total SPAR Group, Inc. equity\u00a018,702\u00a0\u00a0\u00a018,757\u00a0Non-controlling interest\u00a05,696\u00a0\u00a0\u00a04,454\u00a0Total equity\u00a024,398\u00a0\u00a0\u00a023,211\u00a0Total liabilities and equity$\u00a0 43,406\u00a0\u00a0$\u00a0 44,570\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0.gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} \n.gnwtablebottommargin {margin-bottom: 10.0px !important;} \n.gnwcellpaddingleft0 {padding-left: 0.0px !important;} \n.gnwverticalaligntop {vertical-align: top !important;} \n.gnwtextaligncenter {text-align: center !important;} \n.gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} \n.gnwverticalalignbottom {vertical-align: bottom !important;} \n.gnwwhitespacenowrap {white-space: nowrap !important;} \n.gnwtextalignright {text-align: right !important;} \n.gnwcellpaddingright0 {padding-right: 0.0px !important;} \n.gnwunderlinestyle {text-decoration: underline !important;} \n.gnwtextalignleft {text-align: left !important;} \n.gnw_ol {position: relative !important; left: 10px !important;} \n.gnw_ul {position: relative !important; left: 10px !important;} \n.gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} \n.gnw_border_top_solid {border-top: solid black 1px !important;} \n.gnw_border_right_solid {border-right: solid black 1px !important;} \n.gnw_border_bottom_solid {border-bottom: solid black 1px !important;} \n.gnw_border_left_solid {border-left: solid black 1px !important;} \n.gnw_border_top_double {border-top: double black 3px !important;} \n.gnw_border_right_double {border-right: double black 3px !important;} \n.gnw_border_bottom_double {border-bottom: double black 3px !important;} \n.gnw_border_left_double {border-left: double black 3px !important;} \n.gnw_table_border_collapse {border-collapse: collapse !important;} \n.gnw_align_left {text-align: left !important;} \n.gnw_align_center {text-align: center !important;} \n.gnw_align_right {text-align: right !important;} \n.gnw_align_justify {text-align: justify !important;} \n.gnw_vertical_align_top {vertical-align: top !important;} \n.gnw_vertical_align_middle {vertical-align: middle !important;} \n.gnw_vertical_align_bottom {vertical-align: bottom !important;} \n.gnw_padding_left_none {padding-left: 0 !important;} \n.gnw_padding_right_none {padding-right: 0 !important;} \n.gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} \n.gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} \n.gnw_heading {font: 16px Arial; text-align: center !important;} \n.gnw_subhead {font: 12px Arial; text-align: center !important;} \n.gnw_colhead {font: 12px Arial; text-align: center !important;} \n.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} \n.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} \n.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} \n.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \n.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} \n.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} \n.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} \n.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} \n.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} \n.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} \n.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} \n.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} \n.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} \n.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} \n.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} \n.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \n.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} \n.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} \n.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} \n.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} \n.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} \n.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} \n.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} \n.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} \n.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} \n.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} \n.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} \n.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \n.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \n.gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} \n.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} \n.gnw_media_bgcolor {background-color: transparent !important;} \n.gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} \n.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} \ntd.gnw_heading {font: 16px Arial; text-align: center !important;} \ntd.gnw_subhead {font: 12px Arial; text-align: center !important;} \ntd.gnw_colhead {font: 12px Arial; text-align: center !important;} \ntd.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} \ntd.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} \ntd.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} \ntd.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \ntd.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} \ntd.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} \ntd.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} \ntd.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} \ntd.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} \ntd.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} \ntd.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} \ntd.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} \ntd.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} \ntd.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} \ntd.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} \ntd.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \ntd.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} \ntd.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} \ntd.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} \ntd.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} \ntd.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} \ntd.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} \ntd.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} \ntd.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} \ntd.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} \ntd.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} \ntd.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} \ntd.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \ntd.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \ntd.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} \ntd.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} \n;} \n\n          \nCompany Earnings\n\n\n                    Contact:\n                \n\nCompany Contact:James R. SegretoChief Financial OfficerSPAR Group, Inc.(914) 332-4100Investor Contact:Dave MossbergThree Part Advisors(817) 310-0051          \n\n\n\n", "title": "SPAR Group Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2015", "symbols": ["SGRP"], "link": "http://finance.yahoo.com/news/spar-group-announces-financial-results-200500411.html", "date": "55 minutes ago", "_id": {"$oid": "56fc80fcfb1fdb5e34baa8f1"}, "nes": {"MONEY": ["$0.04", "$0.05", "$0.05\u00a0\u00a0$0.12\u00a0\u00a0\u00a0$0.04\u00a0\u00a0$0.15", "$0.05\u00a0\u00a0$0.13\u00a0\u00a0\u00a0$0.04\u00a0\u00a0$0.16", "$0.09", "$0.12", "$0.15", "$1.0 million", "$1.3 million", "$1.9 million", "$119.3 million", "$16.8 million", "$2.7 million", "$3.3 million", "$3.7 million", "$301,000", "$32.3 million", "$498,000", "$5.7 million", "$609,000", "$7.5 million", "$892,000", "$\u00a0 1,028\u00a0\u00a0$\u00a0 2,678\u00a0\u00a0\u00a0$\u00a0 892\u00a0\u00a0$\u00a0 3,268", "$\u00a0 21,448\u00a0\u00a0$\u00a0 20,912\u00a0\u00a02.6%\u00a0$\u00a0 75,667", "$\u00a0 32,276\u00a0\u00a0$\u00a0 32,052 \u00a0\u00a0 \u00a00.7%\u00a0$\u00a0 119,279\u00a0\u00a0$\u00a0 122,021", "$\u00a0 877\u00a0\u00a0$\u00a0 536\u00a0\u00a0\u00a0$\u00a0 505\u00a0\u00a0$\u00a0 628"], "PERCENT": ["0.7 percent", "14.7%\u00a0\u00a018.8%", "17.2%\u00a0\u00a018.2%", "19.5%\u00a0\u00a022.7%", "2.2 percent", "20.7%", "20.7%\u00a0\u00a020.8%", "21.8%\u00a0\u00a022.2%", "23.4%", "23.4%\u00a0\u00a025.2%", "24.5%\u00a0\u00a024.9%", "25.2%", "26.2%\u00a0\u00a028.4%", "29.0%\u00a0\u00a030.0%", "29.7%\u00a0\u00a028.6%", "31.1%", "31.1%\u00a0\u00a031.5%", "31.5%", "31.8%", "31.8%\u00a0\u00a034.5%", "34.5%", "37 percent", "40 percent", "75,617\u00a0\u00a00.1%"], "PERSON": ["Jill Blanchard"], "LOCATION": ["Australia", "Canada", "China", "India", "Japan", "Mexico", "N.Y.", "PLAINS", "South Africa", "U.S.", "United States"], "DATE": ["2014", "2015", "2016", "December 31", "December 31, 2015", "March  30, 2016", "fiscal 2015", "fiscal year 2014", "fiscal year 2015", "fourth quarter", "fourth quarter of 2014", "fourth quarter of 2015"], "ORGANIZATION": ["SPAR Group", "SPAR Group, Inc."]}}
{"content": "\n\n\n\n\n\n\n\n\nFORT WASHINGTON, Pa., March  30, 2016  (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (VTAE), a clinical-stage biotechnology company, today announced the completion of its underwritten public offering of 5,833,333 shares of its common stock at a price to the public of $6.00 per share. In connection with the offering, Vitae has granted the underwriters a 30-day option to purchase up to an additional 875,000 shares of its common stock on the same terms and conditions. The gross offering proceeds to Vitae were approximately $35.0 million. Piper Jaffray & Co. and BMO Capital Markets Corp. acted as joint book-running managers for the offering. Wedbush PacGrow acted as co-manager for the offering. A shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on November 5, 2015. The offering was made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering has been filed with the SEC and is available on the SEC\u2019s web site at www.sec.gov. Copies of the final prospectus supplement and accompanying prospectus relating to these securities may also be obtained by sending a request to: Piper Jaffray & Co. Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota, 55402, or by telephone at (800) 747-3924, or by emailing prospectus@pjc.com; or BMO Capital Markets Corp. by telephone at (800) 414-3627 or by emailing bmoprospectus@bmo.com. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. About Vitae Pharmaceuticals  Vitae Pharmaceuticals is a clinical-stage biotechnology company developing first-in-class product candidates with potential to transform the treatment paradigm for patients with significant unmet medical needs. Initial indications being pursued include psoriasis, other autoimmune disorders, and atopic dermatitis. Vitae\u2019s lead clinical assets include VTP-43742, an oral RORyt inhibitor currently being studied in patients with moderate to severe psoriasis, and VTP-38543, an LXR\u03b2 selective agonist being studied in patients with mild to moderate atopic dermatitis..gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} .gnwtablebottommargin {margin-bottom: 10.0px !important;} .gnwcellpaddingleft0 {padding-left: 0.0px !important;} .gnwverticalaligntop {vertical-align: top !important;} .gnwtextaligncenter {text-align: center !important;} .gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} .gnwverticalalignbottom {vertical-align: bottom !important;} .gnwwhitespacenowrap {white-space: nowrap !important;} .gnwtextalignright {text-align: right !important;} .gnwcellpaddingright0 {padding-right: 0.0px !important;} .gnwunderlinestyle {text-decoration: underline !important;} .gnwtextalignleft {text-align: left !important;} .gnw_ol {position: relative !important; left: 10px !important;} .gnw_ul {position: relative !important; left: 10px !important;} .gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} .gnw_border_top_solid {border-top: solid black 1px !important;} .gnw_border_right_solid {border-right: solid black 1px !important;} .gnw_border_bottom_solid {border-bottom: solid black 1px !important;} .gnw_border_left_solid {border-left: solid black 1px !important;} .gnw_border_top_double {border-top: double black 3px !important;} .gnw_border_right_double {border-right: double black 3px !important;} .gnw_border_bottom_double {border-bottom: double black 3px !important;} .gnw_border_left_double {border-left: double black 3px !important;} .gnw_table_border_collapse {border-collapse: collapse !important;} .gnw_align_left {text-align: left !important;} .gnw_align_center {text-align: center !important;} .gnw_align_right {text-align: right !important;} .gnw_align_justify {text-align: justify !important;} .gnw_vertical_align_top {vertical-align: top !important;} .gnw_vertical_align_middle {vertical-align: middle !important;} .gnw_vertical_align_bottom {vertical-align: bottom !important;} .gnw_padding_left_none {padding-left: 0 !important;} .gnw_padding_right_none {padding-right: 0 !important;} .gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} .gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} .gnw_heading {font: 16px Arial; text-align: center !important;} .gnw_subhead {font: 12px Arial; text-align: center !important;} .gnw_colhead {font: 12px Arial; text-align: center !important;} .gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} .gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} .gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} .gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} .gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} .gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} .gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} .gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} .gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} .gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} .gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} .gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} .gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} .gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} .gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} .gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} .gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} .gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} .gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} .gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} .gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} .gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} .gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} .gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} .gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} .gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} .gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} .gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} .gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} .gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} .gnw_media_bgcolor {background-color: transparent !important;} .gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} .gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} td.gnw_heading {font: 16px Arial; text-align: center !important;} td.gnw_subhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead {font: 12px Arial; text-align: center !important;} td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} td.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} td.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} td.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} td.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} td.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} td.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} td.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} td.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} td.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} ;}           Health Care Industry\n\n\n                    Contact:\n                \n\nINVESTORS:Vitae Pharmaceuticals, Inc.Richard S. Morris, CPAChief Financial Officer(215) 461-2000rmorris@vitaerx.com \u00a0Westwicke PartnersJohn Woolford(443) 213-0506john.woolford@westwicke.com \u00a0MEDIA:6 Degrees PRTony Plohoros\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (908) 591-2839tplohoros@6degreespr.com \u00a0          \n\n\n\n", "title": "Vitae Pharmaceuticals Closes Public Offering of Common Stock", "symbols": ["VTAE"], "link": "http://finance.yahoo.com/news/vitae-pharmaceuticals-closes-public-offering-200500434.html", "date": "55 minutes ago", "_id": {"$oid": "56fc80fcfb1fdb5e34baa8f2"}, "nes": {"DATE": ["March  30, 2016", "November 5, 2015"], "MONEY": ["$35.0 million", "$6.00"], "LOCATION": ["Geneva", "Helvetica", "Minneapolis", "Minnesota", "Pa.", "Verdana", "Vitae", "WASHINGTON"], "ORGANIZATION": ["BMO Capital Markets Corp.", "Nicollet Mall", "Piper Jaffray & Co", "Piper Jaffray & Co.", "Prospectus Department", "SEC", "Securities and Exchange Commission", "Vitae", "Vitae Pharmaceuticals", "Vitae Pharmaceuticals  Vitae Pharmaceuticals", "Vitae Pharmaceuticals, Inc.", "Westwicke PartnersJohn Woolford"], "PERSON": ["S. Morris"]}}
{"content": "\n\n\n\n\n\n\nWALTHAM, Mass., March  30, 2016  (GLOBE NEWSWIRE) -- BeiGene, Ltd. (BGNE) (\u201cBeiGene\u201d), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today reported business highlights and financial results for the fourth quarter and full year 2015.\n\u201c2015 was a productive and transformative year for our company,\u201d said John V. Oyler, Chief Executive Officer of BeiGene. \u201cWe made excellent progress in becoming an innovative global biopharmaceutical company. We advanced our four clinical-stage candidates and demonstrated single agent activity for each. We secured $97 million in private financing from top tier Chinese and U.S. investors, which allowed us to establish global clinical development operations in the United States, Australia, and Taiwan, add key hires to our executive management team, and build up our manufacturing operations in Suzhou. This progress helped pave the way for an initial public offering in February 2016 on the NASDAQ stock exchange, which strengthened our balance sheet with an additional $167 million in net proceeds after underwriting discounts and offering expenses.\u201d Mr. Oyler continued, \u201cIn 2016, we look forward to continuing the momentum with our pipeline, commencing registration and additional combination trials, and providing data readouts and updates for each of our clinical candidates.\u201d 2015 and Recent Business Highlights Clinical Programs: In total, over 400 patients were treated as of March 25, 2016 across four clinical programs, including combination trials. BGB-3111, a potent and highly selective small molecule inhibitor of Bruton\u2019s tyrosine kinase (BTK) Presented initial clinical data in patients with advanced B-cell malignancies in an oral presentation at the 2015 American Society of Hematology (ASH) annual meeting. \u00a0Continued to expand the dose-expansion phase of the BGB-3111 trial globally with patients receiving treatment in Australia, New Zealand, Korea, and the United States.Commenced combination study of BGB-3111 with the anti-CD20 antibody obinutuzumab in patients with chronic lymphocytic leukemia and other B-cell malignancies.Received approval of Clinical Trial Application (CTA) by the Chinese Food and Drug Administration (CFDA) in February 2016 which cleared BGB-3111 for all phases of clinical testing in China.In total, over 100 patients have been treated with BGB-3111 in monotherapy and combination trials as of March 25, 2016.BGB-A317, a humanized monoclonal antibody against the immune checkpoint inhibitor PD-1 Commenced dose-escalation phase of clinical trial in relapsed or refractory solid tumor patients.Received Food and Drug Administration (FDA) clearance of U.S. Investigational New Drug Application (IND).Commenced combination study of BGB-A317 and BGB-290, a PARP inhibitor for the treatment of cancers with mutations in the breast cancer susceptibility gene (BRCA) or deficiencies in homologous recombination or mismatch repair, including ovarian, breast, prostate, colorectal, and pancreatic cancers, as well as platinum-sensitive ovarian cancer.In total, over 100 patients have been treated with BGB-A317 in monotherapy and combination trials as of March 25, 2016.\u00a0\u00a0BGB-290, a highly potent and selective PARP inhibitor Presented Phase I data in an oral presentation at 2015 AACR-NCI-EORTC in November 2015.Completed dose-escalation phase of the Phase I trial in Australia. Dose-expansion phase of the Phase I trial is being initiated.Commenced combination study of BGB-290 and BGB-A317 in February 2016.In total, over 50 patients have been treated with BGB-290 in monotherapy and combination trials as of March 25, 2016.BGB-283, a novel RAF dimer inhibitor that targets both BRAF- and RAS-mutated cancers Completed the dose-escalation phase of the Phase I trial in Australia and New Zealand to investigate BGB-283 as monotherapy in patients with solid tumors harboring B-RAF mutations or other aberrations in the RAS-MAPK pathway.Initiated and continued dose-expansion phase of the Phase I trial in patients with solid tumors with BRAF mutations and/or aberrations in the MAPK pathway, including thyroid cancer, colorectal cancer, non-small cell lung cancer and other non-V600E BRAF mutated cancers, and KRAS/NRAS mutated endometrial cancer, colorectal cancer, non-small cell lung cancer and other KRAS/NRAS mutated cancer in Australia and New Zealand.\u00a0Obtained CFDA approval of CTA. Initiated dose-escalation and dose-expansion trials in China.A total of over 150 patients have been treated with BGB-283 as of March 25, 2016. \u00a0Corporate Development: Strengthened Executive Management team with the appointment of Dr. Howard Liang as Chief Financial Officer and Chief Strategy Officer and Dr. RuiRong Yuan as Chief Medical Officer and President of Global Clinical Research and Development.Expanded Scientific Advisory Board with the addition of Dr. Jedd D. Wolchok. \u00a0Repurchased the ex-China rights to BGB-290 from Merck KGaA.Commenced construction of a manufacturing facility in Suzhou, China and made key hires in the areas of process development and manufacturing.Established operations in the United States, Australia, and Taiwan.Expected Upcoming Milestones BGB-3111 (BTK Inhibitor) Initiate combination study with BGB-A317 in the first half of 2016.Present updated dose-escalation and dose-expansion data at medical conferences in 2016.Present data from combination studies at medical conferences in 2016 or 2017.Initiate abbreviated dose-escalation trial followed by registration trials in China during 2016.Initiate global registration program in 2016, pending feedback from regulatory authorities.BGB-A317 (PD-1 Antibody) Present dose-escalation data at a medical conference in 2016.Initiate combination studies in 2016.Present data from combination studies at medical conferences in 2016 or 2017.BGB-290 (PARP Inhibitor) Present updated dose-escalation data at a medical conference in 2016.Present data on combination with BGB-A317 at medical conferences in 2016 or 2017.BGB-283 (RAF Dimer Inhibitor) Present initial clinical data in an oral presentation at American Association for Cancer Research Annual Meeting on April 17, 2016.Fourth Quarter and Full Year 2015 Financial Results Cash, Cash Equivalents, and Short-term Investments were $100.49 million as of December 31, 2015, compared to $44.40 million as of December 31, 2014. The increase reflects net proceeds of $97.35 million received from the issuance of convertible preferred shares in connection with a private placement in April 2015 and a milestone payment from Merck KGaA. The net cash used in operations was $39.84 million and $8.69 million for the years ended December 31, 2015 and 2014, respectively; and capital expenditures were $5.31 million and $0.65 million for the years ended December 31, 2015 and 2014, respectively. In February 2016, BeiGene completed its IPO of 7,590,000 American Depositary Shares (\u201cADSs\u201d) at $24.00 per ADS on the NASDAQ stock exchange. Net proceeds were approximately $167 million after underwriting discounts and offering expenses. In addition, Merck Sharp & Dohme Research GmBH, an affiliate of Merck & Co., elected to exchange a senior promissory note of approximately $15 million including principle and accrued interest for BeiGene\u2019s ordinary shares at the per share IPO price.\u00a0 Revenue for the three and twelve months ended December 31, 2015 was $4.68 million and $8.82 million, respectively, compared with $1.38 million and $13.04 million in the comparable periods in 2014. Changes in revenue are primarily attributable to the difference between revenues recognized in 2014 for payments received for dosing of 5th patients of BGB-283 and BGB-290 in ex-China trials and a payment received in 2015 for dosing of the 5th patient of BBG-283 in China. \u00a0 Research & Development (R&D) Expenses for the three and twelve months ended December 31, 2015 were $28.10 million and $58.25 million, respectively, compared with $6.21 million and $21.86 million in the comparable periods in 2014. The increase in R&D expenses was primarily attributable to increased spending on clinical activities as BGB-3111, BGB-290 and BGB-283 entered dose expansion trials and BGB-A317 commenced a dose-escalation trial in 2015, IND-enabling activities for BGB-A317 and other preclinical programs, and payment to Merck KGaA to repurchase ex-China rights to BGB-290. Additionally, there were increased compensation expenses due to the hiring of more development personnel and increased share option expense ($9.59 million and $4.03 million for 2015 and 2014, respectively). General & Administrative (G&A) Expenses for the three and twelve months ended December 31, 2015 were $2.95 million and $7.31 million, respectively, compared with $1.63 million and $6.93 million in the comparable periods in 2014. The increase in G&A expenses was primarily attributable to increased external legal and accounting expenses in connection with the Series A-2 preferred share financing and the IPO. The G&A share option expense was $0.62 million and $2.61 million for 2015 and 2014, respectively, and the decrease was primarily attributable to the contractual discount in the exchange price of a loan advanced by a senior executive to BeiGene into Series A preferred shares which was treated as a compensation expense in 2014. Net Loss for the three and twelve months ended December 31, 2015 was $27.25 million and $57.10 million, respectively, compared with $3.74 million and $18.55 million in the comparable periods in 2014. Financial Summary Select Consolidated Balance Sheet Data (U.S. GAAP)\u00a0(Amounts in thousands of U.S. Dollars) (unaudited)\u00a0\u00a0\u00a0As of December\u00a031,\u00a0\u00a0\u00a02015\u00a02014\u00a0Cash, cash equivalents, and short\u2011term investments$\u00a0100,486\u00a0$\u00a044,395\u00a0\u00a0Prepaid expenses and other current assets\u00a0\u00a05,783\u00a0\u00a0\u00a02,793\u00a0\u00a0Property and equipment, net\u00a0\u00a06,612\u00a0\u00a0\u00a05,931\u00a0\u00a0Total assets\u00a0\u00a0116,764\u00a0\u00a0\u00a053,621\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Accounts payable\u00a0\u00a08,980\u00a0\u00a0\u00a02,794\u00a0\u00a0Senior promissory note\u00a0\u00a014,598\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u2014\u00a0\u00a0Long-term bank loan\u00a0\u00a06,188\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u2014\u00a0\u00a0Total shareholders\u2019 equity (deficit)$\u00a0(101,765)$\u00a0(53,041)\u00a0\u00a0\u00a0\u00a0\u00a0Consolidated Statements of Operations (U.S. GAAP)\u00a0\u00a0(Amounts in thousands of U.S. Dollars, except for number of ADSs and per ADS data) (unaudited)\u00a0\u00a0\u00a0\u00a0\u00a0Three Months EndedDecember 31,\u00a0Year EndedDecember 31,\u00a0\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0\u00a0\u00a02015\u00a0\u00a02014Collaboration revenue$\u00a04,677\u00a0$\u00a01,381\u00a0$\u00a08,816\u00a0$\u00a013,035\u00a0\u00a0Operating expenses:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Research and development\u00a0\u00a028,103\u00a0\u00a0\u00a06,208\u00a0\u00a0\u00a058,250\u00a0\u00a0\u00a021,862\u00a0\u00a0General and administrative\u00a0\u00a02,950\u00a0\u00a0\u00a01,626\u00a0\u00a0\u00a07,311\u00a0\u00a0\u00a06,930\u00a0\u00a0Total operating expenses\u00a0\u00a031,053\u00a0\u00a0\u00a07,834\u00a0\u00a0\u00a065,561\u00a0\u00a0\u00a028,792\u00a0\u00a0Loss from operations\u00a0\u00a0(26,376)\u00a0\u00a0(6,453)\u00a0\u00a0(56,745)\u00a0\u00a0(15,757)\u00a0Interest income (expense)\u00a0\u00a0113\u00a0\u00a0\u00a0(277)\u00a0\u00a0559\u00a0\u00a0\u00a0(3,512)\u00a0Other income (expense)\u00a0\u00a0(987)\u00a0\u00a02,992\u00a0\u00a0\u00a0(916)\u00a0\u00a0723\u00a0\u00a0Net loss$\u00a0(27,250)$\u00a0(3,738)$\u00a0(57,102)$\u00a0(18,546)\u00a0Less: net loss attributable to non-controlling interests$\u00a0\u00a0\u00a0\u00a0\u00a0\u2014\u00a0\u00a0\u00a013\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u2014\u00a0\u00a0\u00a0(268)\u00a0Net loss attributable to ordinary shareholders$\u00a0(27,250)$\u00a0(3,751)$\u00a0(57,102)$\u00a0(18,278)\u00a0Net loss per ADS, basic and diluted$\u00a0(3.05)$\u00a0(0.45)$\u00a0(6.71)$\u00a0(2.38)\u00a0Weighted\u2011average number of ADSs used in net loss per ADS - basic and diluted\u00a0\u00a08,936,469\u00a0\u00a0\u00a08,347,419\u00a0\u00a0\u00a08,507,482\u00a0\u00a0\u00a07,681,356\u00a0\u00a0 Consolidated Statements of Comprehensive Loss (U.S. GAAP)\u00a0(Amounts in thousands of U.S. Dollars) (unaudited)\u00a0\u00a0Three Months EndedDecember 31,Year EndedDecember 31,\u00a0\u00a0\u00a02015\u00a0\u00a0\u00a02014\u00a0\u00a020152014Net loss$\u00a0(27,250)$\u00a0(3,738)$\u00a0(57,102)$\u00a0(18,546)Other comprehensive income/(loss), net of tax of nil:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Foreign currency translation adjustments\u00a0\u00a0(240)\u00a0\u00a0(103)\u00a0\u00a0(749)\u00a0\u00a0(168)Unrealized holding loss\u00a0\u00a0(436)\u00a0\u00a0(47)\u00a0\u00a0(1,160)\u00a0\u00a0(47)Comprehensive loss$\u00a0(27,926)$\u00a0(3,888)$\u00a0(59,011)$\u00a0(18,761)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0About BeiGene BeiGene is a global, clinical-stage, research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapeutics. With a team of over 200 scientists, clinicians and staff in China, the United States, Australia and Taiwan, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is working to create combination solutions aimed to have both a meaningful and a lasting impact on cancer patients. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene\u2019s financial condition, results of operations and business outlook, the sufficiency of its cash, cash equivalents and short-term investments, momentum of its product pipeline, as well as the advancement of, and anticipated development and regulatory milestones and plans related to BeiGene\u2019s product candidates and clinical trials, including commencing registration and combination trials, and providing data readouts and updates for its clinical candidates.\u00a0 Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors, including BeiGene's ability to demonstrate the efficacy and safety of its drug candidates, the clinical results for its drug candidates, which may not support further development, actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials, BeiGene's ability to achieve market acceptance in the medical community necessary for commercial success, BeiGene's ability to obtain and maintain protection of intellectual property for its technology and drugs, BeiGene's reliance on third parties to conduct preclinical studies and clinical trials, BeiGene\u2019s limited operating history and BeiGene's ability to obtain additional funding for operations and to complete the development and commercialization of its drug candidates, as well as those risks more fully discussed in the section entitled \"Risk Factors\" in the final prospectus related to BeiGene's initial public offering filed with the U.S. Securities and Exchange Commission pursuant to Rule 424(b) of the Securities Act of 1933, as amended, as well as discussions of potential risks, uncertainties, and other important factors in BeiGene's subsequent filings with the U.S. Securities and Exchange Commission.\u00a0 All information in this press release is as of the date of this press release, and BeiGene undertakes no duty to update such information unless required by law..gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} \n.gnwtablebottommargin {margin-bottom: 10.0px !important;} \n.gnwcellpaddingleft0 {padding-left: 0.0px !important;} \n.gnwverticalaligntop {vertical-align: top !important;} \n.gnwtextaligncenter {text-align: center !important;} \n.gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} \n.gnwverticalalignbottom {vertical-align: bottom !important;} \n.gnwwhitespacenowrap {white-space: nowrap !important;} \n.gnwtextalignright {text-align: right !important;} \n.gnwcellpaddingright0 {padding-right: 0.0px !important;} \n.gnwunderlinestyle {text-decoration: underline !important;} \n.gnwtextalignleft {text-align: left !important;} \n.gnw_ol {position: relative !important; left: 10px !important;} \n.gnw_ul {position: relative !important; left: 10px !important;} \n.gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} \n.gnw_border_top_solid {border-top: solid black 1px !important;} \n.gnw_border_right_solid {border-right: solid black 1px !important;} \n.gnw_border_bottom_solid {border-bottom: solid black 1px !important;} \n.gnw_border_left_solid {border-left: solid black 1px !important;} \n.gnw_border_top_double {border-top: double black 3px !important;} \n.gnw_border_right_double {border-right: double black 3px !important;} \n.gnw_border_bottom_double {border-bottom: double black 3px !important;} \n.gnw_border_left_double {border-left: double black 3px !important;} \n.gnw_table_border_collapse {border-collapse: collapse !important;} \n.gnw_align_left {text-align: left !important;} \n.gnw_align_center {text-align: center !important;} \n.gnw_align_right {text-align: right !important;} \n.gnw_align_justify {text-align: justify !important;} \n.gnw_vertical_align_top {vertical-align: top !important;} \n.gnw_vertical_align_middle {vertical-align: middle !important;} \n.gnw_vertical_align_bottom {vertical-align: bottom !important;} \n.gnw_padding_left_none {padding-left: 0 !important;} \n.gnw_padding_right_none {padding-right: 0 !important;} \n.gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} \n.gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} \n.gnw_heading {font: 16px Arial; text-align: center !important;} \n.gnw_subhead {font: 12px Arial; text-align: center !important;} \n.gnw_colhead {font: 12px Arial; text-align: center !important;} \n.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} \n.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} \n.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} \n.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \n.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} \n.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} \n.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} \n.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} \n.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} \n.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} \n.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} \n.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} \n.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} \n.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} \n.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} \n.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \n.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} \n.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} \n.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} \n.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} \n.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} \n.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} \n.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} \n.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} \n.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} \n.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} \n.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} \n.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \n.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \n.gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} \n.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} \n.gnw_media_bgcolor {background-color: transparent !important;} \n.gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} \n.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} \ntd.gnw_heading {font: 16px Arial; text-align: center !important;} \ntd.gnw_subhead {font: 12px Arial; text-align: center !important;} \ntd.gnw_colhead {font: 12px Arial; text-align: center !important;} \ntd.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} \ntd.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} \ntd.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} \ntd.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \ntd.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} \ntd.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} \ntd.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} \ntd.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} \ntd.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} \ntd.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} \ntd.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} \ntd.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} \ntd.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} \ntd.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} \ntd.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} \ntd.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \ntd.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} \ntd.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} \ntd.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} \ntd.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} \ntd.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} \ntd.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} \ntd.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} \ntd.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} \ntd.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} \ntd.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} \ntd.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} \ntd.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} \ntd.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} \ntd.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} \ntd.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} \n;} \n\n          \nHealth Care IndustryAustralia\n\n\n                    Contact:\n                \n\nInvestor/Media ContactLucy Li, Ph.D.+1 781-801-1800ir@beigene.commedia@beigene.com          \n\n\n\n", "title": "BeiGene Reports Fourth Quarter and Full Year 2015 Financial Results", "symbols": ["UG"], "link": "http://finance.yahoo.com/news/beigene-reports-fourth-quarter-full-200500588.html", "date": "55 minutes ago", "_id": {"$oid": "56fc80fcfb1fdb5e34baa8f3"}, "nes": {"DATE": ["2015", "2016", "2017", "April 17, 2016", "April 2015", "December 31, 2014", "December 31, 2015", "February 2016", "Fourth Quarter", "March  30, 2016", "March 25", "March 25, 2016", "November 2015", "first half of 2016", "fourth quarter"], "MONEY": ["$100.49 million", "$167 million", "$44.40 million", "$97 million", "$97.35 million"], "LOCATION": ["Australia", "China", "Korea", "Mass.", "New Zealand", "Suzhou", "Taiwan", "U.S.", "United States", "WALTHAM"], "ORGANIZATION": ["American Association for Cancer Research Annual Meeting", "American Society of Hematology", "CFDA", "CTA", "Chief Financial Officer", "Chinese Food and Drug Administration", "Development.Expanded Scientific Advisory Board", "Food and Drug Administration", "Full Year 2015 Financial Results Cash", "Global Clinical Research", "Ltd.", "Merck KGaA", "NASDAQ", "RAF", "Recent Business Highlights Clinical Programs", "United"], "PERSON": ["Bruton", "Dr. Howard Liang", "Dr. Jedd D. Wolchok", "Dr. RuiRong Yuan", "John V. Oyler", "Mr. Oyler"]}}
{"content": "\n\n\n\n\n\n\n\n\nSouthfield, MI, March  30, 2016  (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (CACC) (referred to as the \u201cCompany\u201d, \u201cCredit Acceptance\u201d, \u201cwe\u201d, \u201cour\u201d, or \u201cus\u201d) has been recognized by Great Place to Work\u00ae and Fortune as No. 47 of the 50 Best Workplaces for Flexibility. This award was based on surveying more than 209,000 randomly selected employees from more than 500 companies of different sizes across a range of industries throughout the country. Great Place to Work\u00ae selected companies for this list by examining their cultural support for programs such as flex-time, compressed work weeks, job sharing and others. Also included was an assessment of whether employees feel their work environment is flexible to them as individuals.  The 50 Best Workplaces for Flexibility ranking is one of a series of rankings by Great Place to Work\u00ae and Fortune based upon team member feedback received from our Great Place to Work\u00ae survey. To see the complete 2016 list of 50 Best Workplaces for Flexibility, visit fortune.com/flexibility. About Credit Acceptance  Since 1972, Credit Acceptance has offered automobile dealers financing programs that enable them to sell vehicles to consumers, regardless of their credit history. Our financing programs are offered through a nationwide network of automobile dealers who benefit from sales of vehicles to consumers who otherwise could not obtain financing; from repeat and referral sales generated by these same customers; and from sales to customers responding to advertisements for our product, but who actually end up qualifying for traditional financing.  Without our financing programs, consumers are often unable to purchase a vehicle or they purchase an unreliable one. Further, as we report to the three national credit reporting agencies, an important ancillary benefit of our programs is that we provide our consumers with an opportunity to improve their lives by improving their credit score and move on to more traditional sources of financing. Credit Acceptance is publicly traded on the NASDAQ under the symbol CACC. For more information, visit creditacceptance.com. About Great Place to Work\u00ae Great Place to Work\u00ae is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, including Best Workplaces lists and workplace reviews, Great Place to Work\u00ae provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. In the United States, Great Place to Work\u00ae produces the annual Fortune \"100 Best Companies to Work For\u00ae\" list and a series of Great Place to Work\u00ae Best Workplaces lists including lists for Millennials, Women, Diversity, Small and Medium Companies and over a half dozen different industry lists..gnwlistitemmarginbottom {margin-bottom: 10.0px !important;} <p>.gnwtablebottommargin {margin-bottom: 10.0px !important;} <p>.gnwcellpaddingleft0 {padding-left: 0.0px !important;} <p>.gnwverticalaligntop {vertical-align: top !important;} <p>.gnwtextaligncenter {text-align: center !important;} <p>.gnwcellparagraphmargin {margin-bottom: 0px !important; margin-top: 0px !important;} <p>.gnwverticalalignbottom {vertical-align: bottom !important;} <p>.gnwwhitespacenowrap {white-space: nowrap !important;} <p>.gnwtextalignright {text-align: right !important;} <p>.gnwcellpaddingright0 {padding-right: 0.0px !important;} <p>.gnwunderlinestyle {text-decoration: underline !important;} <p>.gnwtextalignleft {text-align: left !important;} <p>.gnw_ol {position: relative !important; left: 10px !important;} <p>.gnw_ul {position: relative !important; left: 10px !important;} <p>.gnw_table_border_collapse td {font-size: 12px !important; line-height: 1.25em !important;} <p>.gnw_border_top_solid {border-top: solid black 1px !important;} <p>.gnw_border_right_solid {border-right: solid black 1px !important;} <p>.gnw_border_bottom_solid {border-bottom: solid black 1px !important;} <p>.gnw_border_left_solid {border-left: solid black 1px !important;} <p>.gnw_border_top_double {border-top: double black 3px !important;} <p>.gnw_border_right_double {border-right: double black 3px !important;} <p>.gnw_border_bottom_double {border-bottom: double black 3px !important;} <p>.gnw_border_left_double {border-left: double black 3px !important;} <p>.gnw_table_border_collapse {border-collapse: collapse !important;} <p>.gnw_align_left {text-align: left !important;} <p>.gnw_align_center {text-align: center !important;} <p>.gnw_align_right {text-align: right !important;} <p>.gnw_align_justify {text-align: justify !important;} <p>.gnw_vertical_align_top {vertical-align: top !important;} <p>.gnw_vertical_align_middle {vertical-align: middle !important;} <p>.gnw_vertical_align_bottom {vertical-align: bottom !important;} <p>.gnw_padding_left_none {padding-left: 0 !important;} <p>.gnw_padding_right_none {padding-right: 0 !important;} <p>.gnw_table_border_collapse td.gnw_align_left {padding-left: 0 !important;padding-right: 3px !important;} <p>.gnw_table_border_collapse td.gnw_align_right {padding-left: 3px !important;padding-right: 0 !important;} <p>.gnw_heading {font: 16px Arial; text-align: center !important;} <p>.gnw_subhead {font: 12px Arial; text-align: center !important;} <p>.gnw_colhead {font: 12px Arial; text-align: center !important;} <p>.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} <p>.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} <p>.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} <p>.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} <p>.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} <p>.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} <p>.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} <p>.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} <p>.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} <p>.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} <p>.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} <p>.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} <p>.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} <p>.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} <p>.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} <p>.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} <p>.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} <p>.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} <p>.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} <p>.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} <p>.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} <p>.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} <p>.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} <p>.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} <p>.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} <p>.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>.gnw_news_media_box {margin-top: 15px !important; margin-left: 6px !important; margin-bottom: 6px !important; margin-right: 6px !important; border-width: 1px !important; border-color: #A9A9A9 !important; border-style: solid !important;} <p>.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} <p>.gnw_media_bgcolor {background-color: transparent !important;} <p>.gnw_table {border-collapse: separate !important; border-spacing: 6px !important;} <p>.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} <p>td.gnw_heading {font: 16px Arial; text-align: center !important;} <p>td.gnw_subhead {font: 12px Arial; text-align: center !important;} <p>td.gnw_colhead {font: 12px Arial; text-align: center !important;} <p>td.gnw_colhead_uline {font: 12px Arial; text-align: center !important; border-bottom: solid black 1.0pt;} <p>td.gnw_colhead_dline {font: 12px Arial; text-align: center !important; border-bottom: double black 2.5pt;} <p>td.gnw_label    {font: 12px Arial; vertical-align: bottom !important; text-align: left !important;} <p>td.gnw_label_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>td.gnw_label_uline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 10.0px;} <p>td.gnw_label_uline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 15.0px;} <p>td.gnw_label_uline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 20.0px;} <p>td.gnw_label_uline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 25.0px;} <p>td.gnw_label_uline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt; padding-left: 30.0px;} <p>td.gnw_label_dline_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 10.0px;} <p>td.gnw_label_dline_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 15.0px;} <p>td.gnw_label_dline_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 20.0px;} <p>td.gnw_label_dline_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 25.0px;} <p>td.gnw_label_dline_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt; padding-left: 30.0px;} <p>td.gnw_label_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-top: solid black 1.0pt;} <p>td.gnw_label_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>td.gnw_label_i10 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 10.0px;} <p>td.gnw_label_i15 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 15.0px;} <p>td.gnw_label_i20 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 20.0px;} <p>td.gnw_label_i25 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 25.0px;} <p>td.gnw_label_i30 {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; padding-left: 30.0px;} <p>td.gnw_num\t  {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important;} <p>td.gnw_num_uline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: solid black 1.0pt;} <p>td.gnw_num_ulinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: solid black 1.0pt;} <p>td.gnw_num_dline {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-bottom: double black 2.5pt;} <p>td.gnw_num_dlinetop {font: 12px Arial; vertical-align: bottom !important; text-align: right !important; white-space: nowrap !important; border-top: double black 2.5pt;} <p>td.gnw_data\t  {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; white-space: nowrap !important;} <p>td.gnw_data_uline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: solid black 1.0pt;} <p>td.gnw_data_dline {font: 12px Arial; vertical-align: bottom !important; text-align: left !important; border-bottom: double black 2.5pt;} <p>td.gnw_media_caption {font-size: 8pt !important; font-family: Verdana, Arial, Helvetica, Geneva, Swiss, SunSans-Regular !important;} <p>td.gnw_videotitle {font: bold 12px Arial !important; color: #1d5296 !important;} <p>;} <p>          \n\n\n                    Contact:\n                \n\nInvestor Relations: Douglas W. BuskSenior Vice President and Treasurer(248) 353-2700 Ext. 4432IR@creditacceptance.com          \n\n\n\n", "title": "Credit Acceptance Named as One of the Best Workplaces for Flexibility", "symbols": [], "link": "http://finance.yahoo.com/news/credit-acceptance-named-one-best-200500410.html", "date": "55 minutes ago", "_id": {"$oid": "56fc80fcfb1fdb5e34baa8f4"}, "nes": {"DATE": ["1972", "2016", "March  30, 2016"], "ORGANIZATION": ["Diversity", "Great Place", "MI", "Small and Medium Companies"], "LOCATION": ["Geneva", "Helvetica", "Southfield", "United States", "Verdana"], "PERSON": ["Douglas W. BuskSenior"]}}
